data_1i6d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i6d _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' SG ' HD13 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 HD13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.436 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 CA--C 1.574 1.898 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' A' ' 92' ' ' LEU . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.414 HD12 ' SG ' ' A' ' 14' ' ' CYS . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 HD12 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 . . . . . 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.962 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.171 0.51 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.46 80.23 8.72 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 113.362 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.86 103.82 51.78 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.453 ' SG ' HD13 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.437 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -88.15 61.32 6.21 Favored 'General case' 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 124.034 0.933 . . . . 0.0 110.889 -172.782 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.437 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.05 86.36 2.51 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 119.53 1.059 . . . . 0.0 111.833 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.08 117.69 56.86 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' SG ' HD13 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.432 HD13 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.5 46.81 1.4 Allowed 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 109.21 -175.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.426 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.86 79.13 4.7 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.019 -1.051 . . . . 0.0 112.955 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.23 106.41 47.13 Favored Pre-proline 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.436 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.436 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -121.79 66.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 110.944 -167.048 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.426 ' C4D' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 74.29 1.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.573 0.701 . . . . 0.0 112.323 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -111.9 110.79 54.18 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.424 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -87.47 53.22 2.72 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 111.014 -172.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.424 ' C4D' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.68 76.54 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.527 0.679 . . . . 0.0 111.113 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.09 102.74 53.74 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.455 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -85.27 52.56 2.48 Favored 'General case' 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.577 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.455 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.81 78.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.49 111.14 61.51 Favored Pre-proline 0 CA--C 1.574 1.898 0 O-C-N 121.31 -0.869 . . . . 0.0 111.03 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' A' ' 92' ' ' LEU . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 HD12 ' SG ' ' A' ' 14' ' ' CYS . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -132.51 75.61 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.484 1.252 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.594 -161.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.307 13.0 ptp . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 40.76 21.61 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -105.78 113.8 63.52 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.476 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 HD12 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.96 60.55 3.86 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 123.739 0.816 . . . . 0.0 112.04 -172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.476 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.34 71.17 0.76 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 120.054 1.297 . . . . 0.0 111.849 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.33 110.19 63.04 Favored Pre-proline 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 58.61 4.79 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 N--CA 1.487 1.395 0 O-C-N 121.546 -0.721 . . . . 0.0 110.823 -167.065 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.418 ' C4D' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 71.98 0.85 Allowed 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.937 0.875 . . . . 0.0 113.02 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -107.58 116.51 57.55 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -90.49 62.16 5.17 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 124.13 0.972 . . . . 0.0 110.874 -173.415 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.474 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.29 72.34 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.632 0.729 . . . . 0.0 112.846 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -108.06 114.5 59.72 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -123.92 71.48 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.255 1.365 0 O-C-N 121.629 -0.669 . . . . 0.0 110.589 -161.519 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.433 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.259 . . 57.75 42.89 22.83 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 118.782 2.882 . . . . 0.0 118.782 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.13 113.2 65.95 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.461 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -88.86 62.13 6.24 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 124.023 0.929 . . . . 0.0 110.758 -173.335 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.461 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.49 75.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 112.888 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.76 105.05 50.42 Favored Pre-proline 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.43 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -88.3 66.84 8.54 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 . . . . . 0 N--CA 1.486 1.349 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.009 178.339 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.43 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 CA--C 1.559 1.3 0 CA-C-O 121.344 0.592 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.286 . . 61.02 37.05 18.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -102.03 110.99 63.73 Favored Pre-proline 0 CA--C 1.575 1.938 0 O-C-N 121.095 -1.003 . . . . 0.0 109.938 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.417 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -88.81 62.56 6.46 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 N--CA 1.486 1.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.48 171.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.417 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 CA--C 1.565 1.53 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.13 105.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.167 1.349 . . . . 0.0 110.718 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -145.41 102.63 4.33 Favored Pre-proline 0 CA--C 1.573 1.845 0 O-C-N 121.107 -0.996 . . . . 0.0 110.124 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -87.01 55.62 3.65 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.655 -172.775 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.474 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 122.041 0.924 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.95 78.42 1.79 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -107.69 110.26 62.59 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -138.95 82.62 1.91 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--O 1.257 1.479 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.487 -172.518 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.21 78.06 1.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.16 113.76 61.96 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.421 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -127.26 79.64 1.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.158 -160.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.421 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.67 71.82 0.8 Allowed 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.946 0.879 . . . . 0.0 112.401 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.95 109.04 61.99 Favored Pre-proline 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.416 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.13 56.81 3.54 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.615 173.562 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.416 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 CA--C 1.561 1.383 0 CA-C-O 121.461 0.648 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 62.11 36.76 15.02 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -101.5 111.81 64.3 Favored Pre-proline 0 CA--C 1.576 1.962 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.73 76.84 7.61 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.794 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 121.056 0.455 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.6 101.38 3.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -102.26 117.56 60.92 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -126.31 79.75 1.87 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.288 -171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.443 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.55 81.04 1.41 Allowed 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.02 109.99 56.94 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -132.21 78.26 1.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.189 0.595 . . . . 0.0 109.586 -174.889 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.52 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.5 t70 . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 3' ' ' ASP . 8.2 m120 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' N ' HD21 ' A' ' 91' ' ' ASN . 17.9 t70 . . . . . 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 3' ' ' ASP . 10.0 m120 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' N ' HD21 ' A' ' 91' ' ' ASN . 15.3 t70 . . . . . 0 CA--C 1.574 1.898 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 3' ' ' ASP . 8.6 m120 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.557 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.8 t70 . . . . . 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.557 HD21 ' N ' ' A' ' 3' ' ' ASP . 9.1 m120 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.496 ' N ' HD21 ' A' ' 91' ' ' ASN . 14.8 t70 . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.496 HD21 ' N ' ' A' ' 3' ' ' ASP . 9.0 m120 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 . . . . . 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.962 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.171 0.51 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.46 80.23 8.72 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 113.362 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.86 103.82 51.78 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.437 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -88.15 61.32 6.21 Favored 'General case' 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 124.034 0.933 . . . . 0.0 110.889 -172.782 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.636 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.05 86.36 2.51 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 119.53 1.059 . . . . 0.0 111.833 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.08 117.69 56.86 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.5 46.81 1.4 Allowed 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 109.21 -175.9 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.647 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.86 79.13 4.7 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.019 -1.051 . . . . 0.0 112.955 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.23 106.41 47.13 Favored Pre-proline 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -121.79 66.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 110.944 -167.048 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.62 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 74.29 1.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.573 0.701 . . . . 0.0 112.323 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -111.9 110.79 54.18 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HMD3 ' A' ' 101' ' ' HEC . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.424 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -87.47 53.22 2.72 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 111.014 -172.65 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.65 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.68 76.54 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.527 0.679 . . . . 0.0 111.113 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.09 102.74 53.74 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.455 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -85.27 52.56 2.48 Favored 'General case' 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.577 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.635 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.81 78.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.49 111.14 61.51 Favored Pre-proline 0 CA--C 1.574 1.898 0 O-C-N 121.31 -0.869 . . . . 0.0 111.03 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -132.51 75.61 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.484 1.252 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.594 -161.627 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.631 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.307 13.0 ptp . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 40.76 21.61 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -105.78 113.8 63.52 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.476 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.96 60.55 3.86 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 123.739 0.816 . . . . 0.0 112.04 -172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.597 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.34 71.17 0.76 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 120.054 1.297 . . . . 0.0 111.849 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.33 110.19 63.04 Favored Pre-proline 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 58.61 4.79 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 N--CA 1.487 1.395 0 O-C-N 121.546 -0.721 . . . . 0.0 110.823 -167.065 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.648 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 71.98 0.85 Allowed 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.937 0.875 . . . . 0.0 113.02 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -107.58 116.51 57.55 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' HMD3 ' A' ' 101' ' ' HEC . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.426 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -90.49 62.16 5.17 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 124.13 0.972 . . . . 0.0 110.874 -173.415 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.672 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.29 72.34 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.632 0.729 . . . . 0.0 112.846 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -108.06 114.5 59.72 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -123.92 71.48 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.255 1.365 0 O-C-N 121.629 -0.669 . . . . 0.0 110.589 -161.519 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.605 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.259 . . 57.75 42.89 22.83 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 118.782 2.882 . . . . 0.0 118.782 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.13 113.2 65.95 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.461 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -88.86 62.13 6.24 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 124.023 0.929 . . . . 0.0 110.758 -173.335 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.6 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.49 75.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 112.888 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.76 105.05 50.42 Favored Pre-proline 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.43 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -88.3 66.84 8.54 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 . . . . . 0 N--CA 1.486 1.349 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.009 178.339 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.607 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 CA--C 1.559 1.3 0 CA-C-O 121.344 0.592 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.286 . . 61.02 37.05 18.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -102.03 110.99 63.73 Favored Pre-proline 0 CA--C 1.575 1.938 0 O-C-N 121.095 -1.003 . . . . 0.0 109.938 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.417 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -88.81 62.56 6.46 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 N--CA 1.486 1.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.48 171.802 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.625 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 CA--C 1.565 1.53 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.13 105.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.167 1.349 . . . . 0.0 110.718 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -145.41 102.63 4.33 Favored Pre-proline 0 CA--C 1.573 1.845 0 O-C-N 121.107 -0.996 . . . . 0.0 110.124 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -87.01 55.62 3.65 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.655 -172.775 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.667 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 122.041 0.924 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.95 78.42 1.79 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -107.69 110.26 62.59 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -138.95 82.62 1.91 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--O 1.257 1.479 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.487 -172.518 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.642 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.21 78.06 1.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.16 113.76 61.96 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.421 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -127.26 79.64 1.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.158 -160.121 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.64 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.67 71.82 0.8 Allowed 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.946 0.879 . . . . 0.0 112.401 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.95 109.04 61.99 Favored Pre-proline 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HMD3 ' A' ' 101' ' ' HEC . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.416 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.13 56.81 3.54 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.615 173.562 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.612 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 CA--C 1.561 1.383 0 CA-C-O 121.461 0.648 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 62.11 36.76 15.02 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -101.5 111.81 64.3 Favored Pre-proline 0 CA--C 1.576 1.962 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD21 HMB1 ' A' ' 101' ' ' HEC . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.73 76.84 7.61 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.794 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.651 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 121.056 0.455 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.6 101.38 3.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -102.26 117.56 60.92 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -126.31 79.75 1.87 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.288 -171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.638 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.55 81.04 1.41 Allowed 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.02 109.99 56.94 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' SG ' HMB1 ' A' ' 101' ' ' HEC . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.514 HD21 HMB1 ' A' ' 101' ' ' HEC . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -132.21 78.26 1.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.189 0.595 . . . . 0.0 109.586 -174.889 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.64 HMC1 HBC3 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 CA--C 1.574 1.898 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.575 1.938 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.573 1.845 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 . . . . . 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 . . . . . 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 CA--C 1.576 1.962 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.171 0.51 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.46 80.23 8.72 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.141 -0.974 . . . . 0.0 113.362 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.86 103.82 51.78 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.055 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.73 -35.99 92.96 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 N-CA-C 119.322 2.778 . . . . 0.0 119.322 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.35 -46.26 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.945 1.832 . . . . 0.0 115.945 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.0 92.13 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 161.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.08 -36.52 68.05 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 119.538 2.575 . . . . 0.0 119.538 169.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -54.35 -47.3 72.72 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 162.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -59.21 -46.54 88.18 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.74 -39.51 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 CA-C-N 119.818 1.19 . . . . 0.0 113.922 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -54.77 -17.12 3.11 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 164.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.99 -38.01 4.48 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.542 2.577 . . . . 0.0 119.542 158.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.32 -31.87 73.23 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -85.27 -39.82 17.29 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -54.4 -30.71 53.08 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 119.632 3.197 . . . . 0.0 119.632 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.8 75.68 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.6 m -94.7 -40.45 9.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 170.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -110.71 132.39 54.24 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.615 1.166 . . . . 0.0 111.889 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -110.01 115.78 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.418 0.628 . . . . 0.0 111.014 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.17 -29.58 69.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -79.59 58.23 2.67 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.963 1.711 . . . . 0.0 113.398 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.28 30.7 25.66 Favored Glycine 0 CA--C 1.555 2.579 0 N-CA-C 121.062 3.185 . . . . 0.0 121.062 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -124.36 148.76 47.3 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.044 1.422 . . . . 0.0 112.355 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -124.72 110.54 14.49 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.87 -99.39 1.35 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.966 -0.459 . . . . 0.0 113.499 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.1 t -74.54 -56.79 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.684 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.49 165.26 17.98 Favored Glycine 0 CA--C 1.563 3.058 0 CA-C-N 119.08 0.854 . . . . 0.0 114.537 158.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.49 178.59 4.86 Favored 'Trans proline' 0 CA--C 1.568 2.175 0 CA-C-N 120.668 2.234 . . . . 0.0 115.932 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.05 112.72 10.45 Favored 'General case' 0 CA--C 1.567 1.623 0 O-C-N 120.412 -1.43 . . . . 0.0 112.863 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -77.84 -0.56 27.73 Favored 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 117.468 2.395 . . . . 0.0 117.468 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -75.27 118.69 18.45 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 110.09 164.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.1 38.82 25.27 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 117.343 1.697 . . . . 0.0 117.343 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -93.7 -36.27 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.6 t -72.3 117.35 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 120.975 1.716 . . . . 0.0 109.968 -174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.38 -7.41 81.74 Favored Glycine 0 CA--C 1.554 2.488 0 N-CA-C 118.851 2.301 . . . . 0.0 118.851 -164.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -78.99 144.48 34.69 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 120.573 2.186 . . . . 0.0 111.901 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -59.92 143.54 51.28 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.4 122.52 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.575 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 66.48 18.22 10.78 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -159.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.71 56.01 2.28 Favored Glycine 0 N--CA 1.487 2.059 0 O-C-N 120.049 -1.657 . . . . 0.0 116.379 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.0 104.52 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.81 103.01 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.449 0.642 . . . . 0.0 110.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.78 -50.25 0.63 Allowed Glycine 0 N--CA 1.487 2.096 0 CA-C-O 119.296 -0.724 . . . . 0.0 114.291 -158.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -86.75 136.91 32.83 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.44 1.12 . . . . 0.0 111.646 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.29 90.57 5.55 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-O 121.407 0.623 . . . . 0.0 111.879 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -76.61 148.66 36.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -66.25 149.2 50.71 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.22 -43.9 99.43 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 116.052 -1.928 . . . . 0.0 116.037 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.51 -29.82 89.88 Favored 'Trans proline' 0 CA--C 1.56 1.779 0 CA-C-N 124.694 2.712 . . . . 0.0 118.981 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.7 tpp -64.59 -44.4 90.79 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.97 -45.98 86.68 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.96 -23.08 65.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 118.956 2.947 . . . . 0.0 118.956 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -65.58 -59.47 3.92 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.13 49.82 Favored Glycine 0 CA--C 1.55 2.276 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.73 -162.16 25.23 Favored Glycine 0 N--CA 1.49 2.248 0 O-C-N 121.811 -0.817 . . . . 0.0 114.971 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.18 152.74 51.94 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.571 0.7 . . . . 0.0 110.868 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -80.82 80.91 7.2 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.765 1.269 . . . . 0.0 113.352 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.7 p -79.62 159.19 72.35 Favored Pre-proline 0 CA--C 1.575 1.942 0 C-N-CA 124.41 1.084 . . . . 0.0 112.853 174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.63 -46.17 31.23 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 C-N-CA 122.852 2.368 . . . . 0.0 117.982 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -54.98 -51.68 65.44 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.215 1.932 . . . . 0.0 116.215 167.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -44.51 95.34 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -58.87 -48.13 82.46 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -62.8 -37.08 85.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.63 -56.54 20.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -57.92 -42.93 85.81 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.57 -16.31 61.75 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 170.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.03 -53.45 25.69 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.762 1.619 . . . . 0.0 112.727 163.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -147.15 106.35 3.87 Favored Pre-proline 0 CA--C 1.575 1.919 0 CA-C-N 120.178 1.354 . . . . 0.0 109.341 166.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -72.97 -40.34 1.84 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 N-CA-C 117.23 1.973 . . . . 0.0 117.23 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.15 -16.31 61.45 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.457 2.391 . . . . 0.0 117.457 171.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.25 -44.98 42.97 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 159.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.29 -58.5 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 119.819 1.19 . . . . 0.0 112.773 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.0 t -99.47 96.83 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -73.89 102.09 3.98 Favored 'General case' 0 CA--C 1.565 1.542 0 CA-C-O 121.54 0.686 . . . . 0.0 112.519 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.61 31.45 7.84 Favored Glycine 0 CA--C 1.553 2.456 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -166.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.7 t -74.1 142.41 45.59 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 118.904 1.352 . . . . 0.0 112.592 163.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 7.24 1.57 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.437 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -78.31 106.58 10.32 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 120.222 1.374 . . . . 0.0 111.455 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.72 75.78 9.61 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-O 122.597 1.189 . . . . 0.0 112.618 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -139.21 128.43 23.99 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -58.37 3.34 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.14 154.03 8.79 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.5 mt -97.57 99.66 6.87 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.339 162.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.74 -35.62 9.48 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 C-N-CA 122.577 2.185 . . . . 0.0 117.576 -175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -79.02 128.98 33.95 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-N 119.102 0.865 . . . . 0.0 112.119 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -50.21 -41.98 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -52.41 -52.58 53.03 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.3 -43.51 92.59 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -60.0 -52.38 65.64 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 170.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.39 82.23 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 170.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -56.06 -56.84 15.88 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 167.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.446 HD11 ' SG ' ' A' ' 14' ' ' CYS . 1.7 tt -60.28 -46.27 90.44 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -60.38 -39.71 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.025 1.284 . . . . 0.0 113.843 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.29 -43.04 74.43 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -63.01 -42.08 99.74 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 165.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.8 mt -60.08 -35.59 75.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.34 -36.7 84.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.94 -43.1 99.41 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 117.722 1.849 . . . . 0.0 117.722 161.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -88.15 61.32 6.21 Favored 'General case' 0 CA--C 1.572 1.814 0 C-N-CA 124.114 0.966 . . . . 0.0 112.085 171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 124.034 0.933 . . . . 0.0 110.889 -172.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.636 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.05 86.36 2.51 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 119.53 1.059 . . . . 0.0 111.833 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.08 117.69 56.86 Favored Pre-proline 0 CA--C 1.575 1.907 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.432 -173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.69 -25.03 21.03 Favored 'Trans proline' 0 CA--C 1.565 2.069 0 N-CA-C 118.815 2.583 . . . . 0.0 118.815 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.05 78.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.31 -39.0 81.68 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 159.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.43 -40.01 75.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 119.323 2.489 . . . . 0.0 119.323 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -54.46 -47.64 72.69 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 163.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -60.01 -44.72 94.38 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 169.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.42 -42.29 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 119.987 1.267 . . . . 0.0 113.623 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.39 -14.81 5.22 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 117.367 2.358 . . . . 0.0 117.367 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -41.62 -41.67 3.34 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.175 2.43 . . . . 0.0 119.175 155.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -66.95 -29.4 69.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.2 m -84.18 -43.17 15.22 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -56.79 -25.02 54.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 -176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -36.32 68.97 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 164.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 41.8 m -100.9 -38.09 8.38 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -112.65 131.15 55.78 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.666 1.186 . . . . 0.0 111.891 -167.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -114.54 108.82 17.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.626 . . . . 0.0 110.917 -168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.75 -26.68 64.22 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.42 56.96 4.18 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 120.681 1.582 . . . . 0.0 113.34 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.55 74.13 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 120.568 2.987 . . . . 0.0 120.568 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -127.72 136.24 51.28 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 118.374 1.087 . . . . 0.0 110.534 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -109.49 102.75 11.59 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.96 -105.24 2.71 Favored Glycine 0 N--CA 1.491 2.35 0 O-C-N 122.049 -0.407 . . . . 0.0 113.295 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.0 t -73.84 -53.83 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 118.886 -0.578 . . . . 0.0 110.83 170.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.95 167.06 16.84 Favored Glycine 0 CA--C 1.563 3.035 0 CA-C-N 119.082 0.855 . . . . 0.0 114.649 158.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.53 170.16 15.66 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.72 2.28 . . . . 0.0 115.335 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -64.06 123.24 18.52 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 120.35 -1.469 . . . . 0.0 113.34 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.1 mt -86.72 10.4 15.91 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -68.32 133.14 48.29 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-N 120.655 1.571 . . . . 0.0 112.023 165.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.36 2.96 88.36 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.547 2.579 . . . . 0.0 119.547 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.268 9.2 p -67.45 -32.86 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -166.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.98 111.28 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-N 120.763 1.619 . . . . 0.0 109.64 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.6 -3.12 74.53 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 118.962 2.345 . . . . 0.0 118.962 -163.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -87.07 146.33 26.12 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.462 2.131 . . . . 0.0 112.674 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.0 m -60.38 138.71 57.93 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.23 124.35 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 123.662 0.785 . . . . 0.0 109.801 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.295 . . 65.04 17.27 11.0 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 118.207 2.669 . . . . 0.0 118.207 -161.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.12 57.26 1.76 Allowed Glycine 0 N--CA 1.487 2.091 0 O-C-N 120.128 -1.607 . . . . 0.0 115.975 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.55 103.35 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -73.81 106.53 5.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.306 0.574 . . . . 0.0 110.381 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -50.33 0.71 Allowed Glycine 0 N--CA 1.489 2.186 0 CA-C-O 119.464 -0.631 . . . . 0.0 114.316 -158.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -92.08 135.25 34.12 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 118.232 1.016 . . . . 0.0 112.195 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.55 95.71 7.22 Favored 'General case' 0 CA--C 1.568 1.666 0 O-C-N 121.694 -0.629 . . . . 0.0 111.471 172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -66.91 145.94 54.92 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.958 172.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -59.05 -45.09 99.53 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-O 116.344 -1.789 . . . . 0.0 115.541 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.08 -28.01 85.22 Favored 'Trans proline' 0 CA--C 1.562 1.9 0 N-CA-C 118.987 2.649 . . . . 0.0 118.987 168.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.4 tpp -62.97 -46.63 86.79 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 164.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -62.02 -47.09 86.32 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 170.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.58 -26.68 67.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.646 2.832 . . . . 0.0 118.646 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.22 -64.67 0.84 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.35 -168.22 48.67 Favored Glycine 0 CA--C 1.553 2.438 0 N-CA-C 116.437 1.335 . . . . 0.0 116.437 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.11 -156.84 22.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -136.51 151.34 49.32 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.712 0.768 . . . . 0.0 111.295 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -82.12 78.76 8.76 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.76 1.267 . . . . 0.0 113.541 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.7 p -74.99 158.36 84.52 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 124.182 0.993 . . . . 0.0 112.997 174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -52.51 -44.53 46.44 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.799 2.333 . . . . 0.0 117.794 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -52.89 -45.22 67.4 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 164.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.95 -45.91 69.53 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.88 -47.84 81.57 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -62.09 -37.81 86.47 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.12 -55.3 30.25 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 166.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -57.1 -42.41 80.75 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.14 -13.42 60.81 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -68.39 -54.96 13.72 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.707 1.594 . . . . 0.0 112.35 163.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.86 105.92 3.94 Favored Pre-proline 0 CA--C 1.574 1.874 0 CA-C-N 119.707 1.139 . . . . 0.0 108.942 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -71.43 -34.46 9.57 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 N-CA-C 117.205 1.963 . . . . 0.0 117.205 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -38.81 92.24 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 170.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.0 86.17 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 169.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.0 -57.01 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 119.587 1.085 . . . . 0.0 112.6 174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.78 98.91 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -73.76 102.39 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.575 0.703 . . . . 0.0 112.581 -172.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.5 32.32 7.78 Favored Glycine 0 CA--C 1.552 2.345 0 N-CA-C 117.966 1.946 . . . . 0.0 117.966 -166.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -79.46 135.38 36.64 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 118.845 1.322 . . . . 0.0 111.947 163.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -74.65 13.43 0.62 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -75.14 106.45 6.66 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 120.594 -1.316 . . . . 0.0 111.463 171.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.92 73.83 8.94 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.838 1.304 . . . . 0.0 113.01 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -138.6 127.7 24.08 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.98 -57.59 3.87 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.02 151.65 6.99 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 115.757 1.063 . . . . 0.0 115.757 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.65 101.17 9.74 Favored Pre-proline 0 CA--C 1.574 1.876 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.414 163.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.17 -35.33 8.83 Favored 'Trans proline' 0 CA--C 1.564 2.007 0 N-CA-C 118.055 2.29 . . . . 0.0 118.055 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -80.01 127.45 32.29 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 119.347 0.976 . . . . 0.0 112.024 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.15 -45.39 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 167.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -53.17 -46.41 68.91 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 171.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -63.36 -41.81 98.85 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -59.17 -51.5 69.72 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.1 75.97 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 169.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -55.16 -54.62 41.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.0 tt -59.9 -43.93 94.55 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.251 83.7 mt -64.85 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 120.002 1.274 . . . . 0.0 113.13 174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.83 -44.62 63.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 160.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.18 -47.79 82.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 168.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.25 -33.97 71.66 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.66 -42.83 99.44 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 163.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.21 -40.53 99.11 Favored Glycine 0 CA--C 1.555 2.538 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 164.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.5 46.81 1.4 Allowed 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 118.627 1.214 . . . . 0.0 113.629 171.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 109.21 -175.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.647 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.558 1.286 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.86 79.13 4.7 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.019 -1.051 . . . . 0.0 112.955 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -117.23 106.41 47.13 Favored Pre-proline 0 CA--C 1.575 1.935 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.129 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.51 -35.58 95.46 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 N-CA-C 119.603 2.886 . . . . 0.0 119.603 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.42 -49.42 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.48 81.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 161.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 -35.42 57.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 119.402 2.521 . . . . 0.0 119.402 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -60.48 -46.01 91.65 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.277 63.4 pttt -64.37 -39.21 93.43 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -62.52 -40.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.368 0 CA-C-N 120.38 1.446 . . . . 0.0 113.445 167.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -55.95 -13.83 2.13 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 163.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.19 -36.69 10.16 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 119.53 2.572 . . . . 0.0 119.53 160.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.57 -27.18 67.53 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -87.01 -41.59 13.76 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.84 -26.07 57.62 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 119.841 3.275 . . . . 0.0 119.841 -172.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.26 78.06 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 165.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.8 m -94.81 -37.98 10.97 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -115.6 130.75 56.98 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 124.677 1.191 . . . . 0.0 111.402 -167.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -110.83 117.49 33.56 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.482 0.658 . . . . 0.0 111.334 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.71 -32.55 71.79 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 172.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -77.93 56.86 1.63 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.76 1.618 . . . . 0.0 113.773 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.84 28.38 31.31 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 120.683 3.033 . . . . 0.0 120.683 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -121.12 140.43 51.99 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.068 1.434 . . . . 0.0 111.964 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.54 114.95 21.94 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.752 0.821 . . . . 0.0 108.805 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.73 -99.95 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 O-C-N 121.827 -0.546 . . . . 0.0 113.508 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.3 t -73.73 -57.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 119.065 -0.493 . . . . 0.0 110.588 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.79 168.31 21.4 Favored Glycine 0 CA--C 1.561 2.945 0 CA-C-N 118.819 0.736 . . . . 0.0 114.594 157.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.99 -179.42 3.0 Favored 'Trans proline' 0 CA--C 1.567 2.138 0 CA-C-N 120.568 2.184 . . . . 0.0 115.716 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -74.41 121.79 21.97 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 120.224 -1.548 . . . . 0.0 112.413 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.21 23.33 1.57 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 116.73 2.122 . . . . 0.0 116.73 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -98.77 122.5 42.09 Favored 'General case' 0 CA--C 1.564 1.516 0 C-N-CA 124.631 1.172 . . . . 0.0 108.974 168.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 43.57 20.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -166.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.49 -36.24 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.75 116.5 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-N 121.42 1.918 . . . . 0.0 109.503 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.85 -14.71 64.72 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -163.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -69.15 139.89 54.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 120.188 1.994 . . . . 0.0 112.936 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -54.89 142.82 28.06 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.83 124.59 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.281 . . 67.37 20.31 9.98 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 -158.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 53.52 4.06 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 119.892 -1.755 . . . . 0.0 116.703 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.4 104.52 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 161.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -75.34 103.55 5.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.703 -0.623 . . . . 0.0 110.294 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.81 -51.36 0.62 Allowed Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.469 -0.628 . . . . 0.0 114.104 -159.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -85.59 131.39 34.36 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 118.195 0.998 . . . . 0.0 110.845 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -82.33 92.24 6.94 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.605 -0.684 . . . . 0.0 111.572 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -72.56 157.04 38.33 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 p -65.49 144.93 56.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.085 -1.009 . . . . 0.0 113.471 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.17 -42.92 83.73 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -60.25 -32.32 94.13 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 166.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.1 tpp -67.36 -42.87 82.73 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 163.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -63.01 -48.33 79.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.97 28.32 0.92 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 172.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -76.52 -61.17 2.05 Favored 'General case' 0 CA--C 1.569 1.699 0 O-C-N 120.457 -1.402 . . . . 0.0 114.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.97 89.42 1.28 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.866 0.757 . . . . 0.0 114.671 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.22 -178.09 39.68 Favored Glycine 0 N--CA 1.484 1.888 0 CA-C-O 121.968 0.76 . . . . 0.0 114.936 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.85 155.61 43.86 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.237 1.018 . . . . 0.0 111.202 172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -82.35 79.58 8.77 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.757 1.265 . . . . 0.0 112.916 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.3 p -76.04 157.88 82.86 Favored Pre-proline 0 CA--C 1.575 1.917 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.895 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -51.43 -46.65 30.27 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.841 2.361 . . . . 0.0 117.491 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -51.44 -48.76 62.62 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 165.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.85 -44.33 81.27 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.6 mt -57.78 -48.2 80.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 170.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.67 -37.8 85.4 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.29 -44.91 82.19 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 168.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.48 -43.02 95.48 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.91 -17.65 63.35 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 168.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.6 m -71.96 -56.6 5.38 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 120.421 1.464 . . . . 0.0 112.348 161.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -142.24 104.54 5.58 Favored Pre-proline 0 CA--C 1.572 1.809 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -57.22 -42.61 61.06 Favored 'Trans proline' 0 CA--C 1.561 1.87 0 N-CA-C 118.275 2.375 . . . . 0.0 118.275 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -19.38 60.55 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -43.02 91.94 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.24 -58.73 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 CA-C-N 119.044 0.838 . . . . 0.0 112.096 172.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.83 92.15 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 120.244 1.384 . . . . 0.0 107.563 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -75.68 110.45 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 111.917 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.49 33.55 9.23 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 -162.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -73.61 135.43 43.84 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.192 -1.181 . . . . 0.0 111.476 159.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -75.59 14.96 0.54 Allowed 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 117.271 2.323 . . . . 0.0 117.271 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.426 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.4 ttt -79.4 110.34 14.61 Favored 'General case' 0 CA--C 1.562 1.437 0 O-C-N 120.808 -1.183 . . . . 0.0 111.094 172.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.74 77.97 8.52 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.531 1.158 . . . . 0.0 112.387 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -142.58 128.17 19.12 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -61.77 1.88 Allowed 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.47 155.64 11.51 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -98.61 102.89 16.07 Favored Pre-proline 0 CA--C 1.575 1.904 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.659 162.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 -34.2 10.81 Favored 'Trans proline' 0 CA--C 1.566 2.122 0 N-CA-C 117.934 2.244 . . . . 0.0 117.934 -176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.0 124.88 28.42 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 119.429 1.013 . . . . 0.0 112.446 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.27 -44.07 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.41 -46.99 76.59 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.22 -43.85 92.3 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -59.89 -52.69 64.33 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.16 79.04 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -56.6 -55.36 34.91 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.418 HD11 ' SG ' ' A' ' 14' ' ' CYS . 2.2 tt -60.23 -46.36 90.04 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.66 -40.31 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.204 1.366 . . . . 0.0 113.815 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -43.31 76.52 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 163.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -61.17 -41.97 97.74 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 165.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.25 -34.68 76.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.38 -37.69 88.24 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.37 -10.57 53.68 Favored Glycine 0 CA--C 1.56 2.879 0 N-CA-C 119.754 2.662 . . . . 0.0 119.754 159.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -121.79 66.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 119.354 1.577 . . . . 0.0 109.597 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 110.944 -167.048 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.62 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 74.29 1.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.573 0.701 . . . . 0.0 112.323 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -111.9 110.79 54.18 Favored Pre-proline 0 CA--C 1.575 1.918 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.85 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.06 -34.97 98.71 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 119.481 2.839 . . . . 0.0 119.481 176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.03 -46.52 84.07 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.0 83.36 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 162.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.05 -38.9 88.33 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.69 -44.38 85.81 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 164.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -59.59 -45.96 90.35 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 167.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.56 -40.91 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 CA-C-N 119.896 1.225 . . . . 0.0 113.767 167.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -57.01 -16.83 7.86 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.2 -35.73 6.88 Favored Glycine 0 CA--C 1.556 2.626 0 N-CA-C 119.401 2.52 . . . . 0.0 119.401 155.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -63.68 -38.01 89.51 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 163.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -82.36 -40.78 20.88 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -28.02 63.81 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 120.05 3.352 . . . . 0.0 120.05 -172.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.49 77.2 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 167.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -93.94 -39.56 10.6 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -113.56 131.81 55.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.632 1.173 . . . . 0.0 111.751 -167.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -112.95 111.97 23.09 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.368 0.604 . . . . 0.0 111.75 -170.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.1 mt -61.28 -31.4 71.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.86 63.03 7.74 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.534 1.515 . . . . 0.0 112.723 171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.33 38.62 62.61 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 121.256 3.262 . . . . 0.0 121.256 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -122.31 139.48 53.76 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.646 1.223 . . . . 0.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -126.93 106.15 9.11 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.46 -90.23 0.41 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.941 -0.474 . . . . 0.0 113.725 -169.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' O ' HMD3 ' A' ' 101' ' ' HEC . 60.5 t -74.4 -61.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.012 169.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.11 169.67 17.92 Favored Glycine 0 CA--C 1.562 2.973 0 CA-C-N 119.182 0.901 . . . . 0.0 114.728 160.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.84 177.68 5.39 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.588 2.192 . . . . 0.0 115.762 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -71.95 128.73 36.64 Favored 'General case' 0 CA--C 1.569 1.673 0 O-C-N 120.298 -1.501 . . . . 0.0 112.642 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.62 17.14 10.65 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -77.17 123.59 26.63 Favored 'General case' 0 CA--C 1.566 1.589 0 O-C-N 120.53 -1.356 . . . . 0.0 110.443 164.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.64 45.56 65.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 -170.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.251 9.7 p -88.65 -34.96 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.22 116.72 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 CA-C-N 121.011 1.732 . . . . 0.0 109.717 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.4 85.16 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -164.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -81.57 139.08 35.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.994 1.897 . . . . 0.0 111.997 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -55.53 141.57 36.56 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.97 126.14 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.396 -0.815 . . . . 0.0 109.898 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 66.57 22.78 10.5 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.099 2.629 . . . . 0.0 118.099 -159.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.84 52.28 3.59 Favored Glycine 0 N--CA 1.487 2.074 0 O-C-N 119.993 -1.692 . . . . 0.0 116.613 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.25 105.94 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 166.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -75.08 106.48 6.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.534 -0.728 . . . . 0.0 110.17 170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.59 -50.59 0.62 Allowed Glycine 0 N--CA 1.488 2.15 0 CA-C-O 119.403 -0.665 . . . . 0.0 114.455 -160.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -88.01 136.87 32.77 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 118.275 1.038 . . . . 0.0 111.929 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -81.14 91.21 6.1 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 121.665 -0.647 . . . . 0.0 111.607 173.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -73.27 153.3 40.66 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.0 t -64.63 146.54 54.54 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 113.397 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -56.55 -44.11 99.61 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -61.23 -27.08 83.06 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 N-CA-C 119.166 2.718 . . . . 0.0 119.166 166.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.6 ttm -69.46 -43.3 73.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 119.936 1.244 . . . . 0.0 114.132 162.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.01 -49.43 77.44 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 171.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.53 39.39 0.97 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -82.66 -59.39 2.53 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.511 -1.368 . . . . 0.0 113.452 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.21 86.01 1.2 Allowed Glycine 0 N--CA 1.487 2.058 0 CA-C-N 118.679 0.672 . . . . 0.0 114.406 -176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.72 -177.18 43.94 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-O 122.593 1.107 . . . . 0.0 115.537 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.59 152.47 51.61 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.923 0.868 . . . . 0.0 110.516 172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -81.76 76.87 8.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.942 1.353 . . . . 0.0 113.227 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.3 p -75.48 160.74 78.88 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.86 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.49 -47.25 23.3 Favored 'Trans proline' 0 CA--C 1.564 1.987 0 C-N-CA 122.819 2.346 . . . . 0.0 117.775 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -54.67 -54.23 44.42 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 166.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.72 -44.38 93.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.39 -50.46 73.59 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 169.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -62.14 -40.41 95.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.0 -50.09 74.78 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 167.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.82 -45.54 82.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.77 -18.41 61.5 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -73.06 -40.09 65.36 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 121.374 1.897 . . . . 0.0 114.843 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -148.19 99.62 3.67 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-N 121.499 1.954 . . . . 0.0 109.656 167.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -71.64 -34.92 8.51 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 N-CA-C 117.177 1.953 . . . . 0.0 117.177 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -70.7 -19.99 62.71 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 169.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -47.8 37.97 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 164.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.63 -50.32 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 CA-C-N 119.428 1.013 . . . . 0.0 113.374 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.13 97.35 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -75.72 100.16 4.6 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -169.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.08 34.9 5.97 Favored Glycine 0 CA--C 1.555 2.564 0 N-CA-C 117.539 1.775 . . . . 0.0 117.539 -165.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -74.52 137.46 42.48 Favored 'General case' 0 CA--C 1.565 1.53 0 O-C-N 121.59 -0.947 . . . . 0.0 112.392 165.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -69.89 5.05 1.68 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 166.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.424 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.0 ttt -76.19 109.02 9.52 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.188 1.358 . . . . 0.0 112.004 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.11 73.64 10.05 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.643 1.211 . . . . 0.0 112.972 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -134.68 127.82 31.82 Favored 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.48 -60.58 2.21 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.55 145.35 4.62 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.3 mt -93.69 107.03 24.24 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.095 162.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.41 -36.34 1.8 Allowed 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.935 2.424 . . . . 0.0 117.103 177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -77.73 126.28 30.63 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.686 1.13 . . . . 0.0 112.19 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -52.09 -42.48 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 165.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -51.83 -50.72 60.29 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.52 -43.21 93.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 171.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.26 -52.95 61.68 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.64 90.47 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -58.75 -52.64 64.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.98 1.264 . . . . 0.0 114.015 166.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.7 tp -54.41 -49.04 70.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.254 82.3 mt -63.38 -38.56 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.757 -1.116 . . . . 0.0 113.464 175.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.16 -43.22 74.04 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 162.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -62.26 -46.01 90.72 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.28 -32.9 73.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.74 -38.1 89.17 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 161.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.41 99.38 Favored Glycine 0 CA--C 1.555 2.554 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 161.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -87.47 53.22 2.72 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 118.16 0.98 . . . . 0.0 113.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 123.941 0.896 . . . . 0.0 111.014 -172.65 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.65 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.68 76.54 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.527 0.679 . . . . 0.0 111.113 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -116.09 102.74 53.74 Favored Pre-proline 0 CA--C 1.572 1.813 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.635 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.31 -36.18 95.2 Favored 'Trans proline' 0 CA--C 1.563 1.938 0 N-CA-C 119.469 2.834 . . . . 0.0 119.469 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.16 87.14 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 170.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.17 86.36 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.68 -37.64 69.12 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 119.223 2.449 . . . . 0.0 119.223 164.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.1 -46.51 85.41 Favored 'General case' 0 CA--C 1.573 1.843 0 CA-C-N 119.295 1.548 . . . . 0.0 114.399 163.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -58.6 -44.12 89.76 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.48 -41.0 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 119.747 1.158 . . . . 0.0 113.547 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -57.08 -16.8 8.21 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 164.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.23 -41.19 3.78 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 119.212 2.445 . . . . 0.0 119.212 157.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -63.92 -35.78 81.79 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 165.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.45 -42.02 19.06 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -54.87 -27.17 40.52 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.79 -34.61 67.82 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 164.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.5 m -104.69 -39.78 6.23 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -109.82 130.92 55.47 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.707 1.203 . . . . 0.0 111.583 -167.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -108.66 118.24 36.27 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.602 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -75.2 -9.23 58.36 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.745 2.498 . . . . 0.0 117.745 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.18 56.03 1.59 Allowed 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 121.126 1.785 . . . . 0.0 112.602 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.42 34.95 55.23 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 120.695 3.038 . . . . 0.0 120.695 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -124.14 139.01 54.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 118.593 1.197 . . . . 0.0 111.468 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -102.39 107.52 18.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.0 109.478 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.04 -108.65 2.99 Favored Glycine 0 N--CA 1.49 2.278 0 O-C-N 122.111 -0.368 . . . . 0.0 113.184 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.11 -49.66 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.293 170.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.83 167.58 15.37 Favored Glycine 0 CA--C 1.563 3.093 0 CA-C-N 119.213 0.915 . . . . 0.0 114.778 158.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.29 171.66 12.42 Favored 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.767 2.312 . . . . 0.0 116.134 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -72.49 111.95 8.12 Favored 'General case' 0 CA--C 1.569 1.692 0 O-C-N 120.308 -1.495 . . . . 0.0 113.807 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.48 -5.9 47.46 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -63.47 116.35 5.49 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 120.074 1.306 . . . . 0.0 111.782 162.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.0 27.0 42.51 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -168.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.65 -41.1 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 120.617 2.209 . . . . 0.0 116.467 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.86 115.49 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-N 120.495 1.498 . . . . 0.0 109.988 -171.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.14 61.79 Favored Glycine 0 CA--C 1.553 2.446 0 N-CA-C 118.607 2.203 . . . . 0.0 118.607 -164.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -81.69 147.6 29.42 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.512 2.156 . . . . 0.0 112.71 -174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.0 m -59.14 144.57 45.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.29 120.83 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 123.608 0.763 . . . . 0.0 109.449 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 68.41 13.08 8.94 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 118.636 2.828 . . . . 0.0 118.636 -159.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.93 57.23 4.35 Favored Glycine 0 N--CA 1.488 2.114 0 O-C-N 119.902 -1.749 . . . . 0.0 116.213 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.51 105.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -74.94 100.88 4.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.66 -0.65 . . . . 0.0 109.806 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.85 -42.6 0.82 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 115.533 0.973 . . . . 0.0 115.533 -158.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -99.35 136.21 39.64 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 118.925 1.363 . . . . 0.0 111.175 170.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.79 97.84 7.52 Favored 'General case' 0 CA--C 1.567 1.607 0 O-C-N 121.585 -0.697 . . . . 0.0 110.963 171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -78.8 160.96 27.12 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 m -69.09 144.81 53.84 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.646 167.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -58.5 -44.46 99.13 Favored Pre-proline 0 N--CA 1.497 1.897 0 CA-C-O 116.032 -1.937 . . . . 0.0 115.974 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 -26.65 83.15 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.261 2.754 . . . . 0.0 119.261 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 37.7 tpp -69.35 -44.79 70.91 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 163.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.45 -45.44 90.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.63 25.22 0.79 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -79.74 -61.19 2.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.387 -1.445 . . . . 0.0 113.888 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.71 88.47 1.19 Allowed Glycine 0 N--CA 1.488 2.127 0 CA-C-N 118.837 0.744 . . . . 0.0 114.666 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.4 178.84 39.88 Favored Glycine 0 CA--C 1.545 1.967 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.84 156.12 40.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.146 0.974 . . . . 0.0 110.974 170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -82.64 79.83 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.688 1.232 . . . . 0.0 113.318 -170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.0 p -76.15 158.35 82.07 Favored Pre-proline 0 CA--C 1.577 2.006 0 C-N-CA 124.334 1.054 . . . . 0.0 112.902 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.33 -47.75 24.48 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.961 2.441 . . . . 0.0 117.906 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.12 -52.26 59.27 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 165.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.66 97.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -57.53 -49.15 77.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 2.8 pp0? -65.24 -35.58 81.49 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -61.68 -52.89 62.47 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 165.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -57.57 -46.41 84.0 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 mt -73.19 -9.4 58.67 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -71.02 -55.68 7.77 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 120.156 1.344 . . . . 0.0 112.253 159.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -144.17 105.97 4.81 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-N 119.981 1.264 . . . . 0.0 109.255 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -70.53 -37.67 7.05 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 N-CA-C 117.327 2.01 . . . . 0.0 117.327 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -10.85 59.98 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.1 -51.24 13.97 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 120.449 1.477 . . . . 0.0 114.267 160.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -53.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.3 94.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -79.03 101.66 7.94 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 121.707 0.765 . . . . 0.0 112.807 -165.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.04 36.01 4.86 Favored Glycine 0 CA--C 1.554 2.475 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -85.86 135.59 33.64 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.56 1.18 . . . . 0.0 112.343 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 pttt -74.16 19.88 0.12 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.455 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.48 109.88 11.79 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.471 -1.393 . . . . 0.0 111.168 173.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.18 69.73 7.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 123.175 1.464 . . . . 0.0 113.545 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -142.05 124.89 16.04 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.24 6.47 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.85 151.88 6.93 Favored Glycine 0 N--CA 1.483 1.813 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -97.76 102.46 13.37 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 117.757 -1.116 . . . . 0.0 108.88 166.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 -33.66 21.75 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.653 2.235 . . . . 0.0 117.572 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -79.11 123.64 27.54 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-N 119.026 0.83 . . . . 0.0 111.933 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 tp -49.61 -43.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 163.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -53.69 -44.3 69.63 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.73 -46.55 84.87 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 168.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -59.85 -51.09 71.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.68 91.93 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -59.94 -50.31 74.26 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.513 1.506 . . . . 0.0 114.492 166.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.67 -48.11 69.77 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 167.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.262 66.7 mt -69.07 -29.9 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 119.842 1.201 . . . . 0.0 114.15 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.29 -46.14 86.65 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 121.463 1.938 . . . . 0.0 115.705 158.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.17 -47.65 85.06 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 173.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -62.7 -39.8 95.16 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 162.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.48 99.66 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 117.812 1.885 . . . . 0.0 117.812 161.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -85.27 52.56 2.48 Favored 'General case' 0 CA--C 1.576 1.952 0 CA-C-N 118.315 1.058 . . . . 0.0 113.774 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 117.681 -1.152 . . . . 0.0 111.577 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.635 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.81 78.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -108.49 111.14 61.51 Favored Pre-proline 0 CA--C 1.574 1.898 0 O-C-N 121.31 -0.869 . . . . 0.0 111.03 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.29 -26.32 20.94 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 N-CA-C 118.604 2.501 . . . . 0.0 118.604 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.06 86.6 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 167.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.49 87.44 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 161.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.07 -36.61 56.78 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.317 2.487 . . . . 0.0 119.317 166.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.35 -45.05 92.46 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 169.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -67.68 -38.61 83.95 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -60.37 -41.53 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 120.104 1.32 . . . . 0.0 113.429 166.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.21 -12.75 5.77 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 167.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.68 -38.06 5.39 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.361 2.505 . . . . 0.0 119.361 151.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -71.32 -7.99 50.72 Favored 'General case' 0 CA--C 1.579 2.067 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 166.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -110.03 -40.9 4.6 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -56.37 -28.08 58.06 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 119.648 3.203 . . . . 0.0 119.648 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.91 -34.91 70.33 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 167.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 m -96.2 -40.8 9.0 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 116.099 1.888 . . . . 0.0 116.099 168.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -109.75 144.27 38.41 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 122.957 1.36 . . . . 0.0 112.904 -167.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -106.53 140.66 39.06 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.794 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.6 mt -102.11 22.92 12.37 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 162.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -106.08 32.13 4.62 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.282 -1.511 . . . . 0.0 114.663 175.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.52 1.63 38.11 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 120.351 2.9 . . . . 0.0 120.351 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -137.22 145.02 43.12 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 125.03 1.332 . . . . 0.0 109.061 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -80.93 161.01 24.52 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.67 -107.66 0.95 Allowed Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.592 -0.692 . . . . 0.0 112.761 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.81 -51.2 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-N 117.569 0.685 . . . . 0.0 111.295 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.28 175.96 32.44 Favored Glycine 0 CA--C 1.563 3.05 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 159.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.03 165.76 22.96 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.993 2.462 . . . . 0.0 115.162 172.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -71.38 125.46 27.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.492 -1.38 . . . . 0.0 112.399 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -89.91 18.58 5.57 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.56 115.84 6.86 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.843 1.201 . . . . 0.0 112.072 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.94 35.35 90.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 117.724 1.85 . . . . 0.0 117.724 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.8 p -67.87 -22.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -71.73 108.05 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 119.847 1.203 . . . . 0.0 109.833 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.09 -4.07 67.38 Favored Glycine 0 CA--C 1.556 2.624 0 N-CA-C 119.101 2.4 . . . . 0.0 119.101 -163.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -98.62 150.62 21.56 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 120.334 2.067 . . . . 0.0 112.309 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.3 m -59.07 143.32 48.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.26 126.92 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 123.511 0.724 . . . . 0.0 109.623 174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.303 . . 67.06 26.4 8.95 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -158.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 54.48 3.33 Favored Glycine 0 N--CA 1.487 2.097 0 O-C-N 120.127 -1.608 . . . . 0.0 116.443 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -134.48 100.3 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 160.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -74.43 98.66 3.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.554 -0.716 . . . . 0.0 109.681 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.58 -26.25 2.55 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 116.989 1.555 . . . . 0.0 116.989 -155.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -106.39 140.67 38.94 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 119.873 1.837 . . . . 0.0 110.511 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -78.99 96.73 5.83 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 121.561 -0.712 . . . . 0.0 111.512 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.74 164.9 23.33 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 81.5 p -74.71 145.11 43.35 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.886 165.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -55.08 -45.56 99.82 Favored Pre-proline 0 CA--C 1.576 1.98 0 CA-C-O 115.755 -2.069 . . . . 0.0 115.665 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -56.76 -32.0 89.98 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 N-CA-C 119.635 2.898 . . . . 0.0 119.635 167.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.4 tpp -66.35 -45.04 81.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 165.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -67.38 -43.61 80.94 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.44 13.1 1.3 Allowed 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 168.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -72.8 -56.39 5.3 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 120.219 1.372 . . . . 0.0 114.104 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.6 86.25 0.77 Allowed Glycine 0 N--CA 1.487 2.064 0 N-CA-C 114.837 0.695 . . . . 0.0 114.837 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.16 -176.59 45.87 Favored Glycine 0 CA--C 1.544 1.89 0 CA-C-O 122.997 1.332 . . . . 0.0 116.057 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -126.71 150.54 48.97 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.213 -0.993 . . . . 0.0 110.107 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -80.37 74.84 7.21 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.573 1.178 . . . . 0.0 113.56 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.6 p -68.74 157.91 87.25 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.128 0.971 . . . . 0.0 113.213 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.33 -46.52 30.91 Favored 'Trans proline' 0 CA--C 1.565 2.037 0 C-N-CA 122.759 2.306 . . . . 0.0 117.663 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.48 -52.32 54.9 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 164.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.73 95.37 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -59.53 -48.59 81.06 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.292 3.2 pp0? -62.1 -35.0 77.39 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.87 -55.49 32.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 163.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.93 -41.99 88.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.59 -11.47 60.44 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 170.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 m -73.34 -56.52 4.96 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.685 1.584 . . . . 0.0 112.032 161.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -141.09 105.11 6.13 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-N 119.894 1.224 . . . . 0.0 109.403 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.21 -32.04 7.07 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 N-CA-C 117.381 2.031 . . . . 0.0 117.381 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -36.19 83.25 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.98 -45.05 78.85 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 167.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.56 -46.32 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.33 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -76.39 103.37 6.36 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.479 1.133 . . . . 0.0 113.291 -173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.13 40.29 4.32 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -166.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.4 t -83.83 151.3 25.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -69.21 -11.04 60.45 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 163.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.61 103.87 3.7 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 120.494 1.497 . . . . 0.0 112.72 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.22 79.92 9.37 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-O 122.491 1.138 . . . . 0.0 111.622 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -140.53 130.44 24.58 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.59 -63.45 1.34 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.61 155.86 11.87 Favored Glycine 0 CA--C 1.546 2.006 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.16 97.31 5.08 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 163.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.64 -38.1 8.54 Favored 'Trans proline' 0 CA--C 1.565 2.064 0 C-N-CA 122.608 2.205 . . . . 0.0 117.782 -173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -79.94 123.82 28.14 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.119 0.872 . . . . 0.0 110.878 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 tt -56.08 -31.27 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 116.885 2.18 . . . . 0.0 116.885 169.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -52.55 -51.22 60.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.83 -39.86 75.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 167.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 mtm-85 -62.81 -57.95 9.11 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.87 -39.87 82.65 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 171.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -57.18 -51.04 70.9 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.74 -44.11 93.94 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.18 -45.24 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 124.134 0.973 . . . . 0.0 113.544 172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.49 -45.74 66.3 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 162.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -61.22 -46.24 91.26 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 170.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.78 -41.68 74.41 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.87 -45.59 89.83 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 165.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.06 9.91 10.98 Favored Glycine 0 CA--C 1.557 2.695 0 N-CA-C 120.12 2.808 . . . . 0.0 120.12 166.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -132.51 75.61 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 119.629 1.714 . . . . 0.0 107.503 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 N--CA 1.484 1.252 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.594 -161.627 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.631 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.307 13.0 ptp . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 40.76 21.61 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -105.78 113.8 63.52 Favored Pre-proline 0 CA--C 1.576 1.974 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.247 -173.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -35.4 98.77 Favored 'Trans proline' 0 CA--C 1.563 1.97 0 N-CA-C 119.742 2.939 . . . . 0.0 119.742 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.06 -46.97 78.99 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.4 -44.27 76.03 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 159.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.73 -37.32 61.25 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 119.504 2.562 . . . . 0.0 119.504 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.62 -48.35 79.67 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.513 1.657 . . . . 0.0 114.73 167.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.282 64.6 pttt -66.69 -38.53 86.98 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.6 t -59.35 -40.76 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-N 120.601 1.546 . . . . 0.0 113.537 165.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.91 -11.74 2.63 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 117.408 2.373 . . . . 0.0 117.408 167.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.78 9.1 Favored Glycine 0 CA--C 1.554 2.519 0 N-CA-C 119.852 2.701 . . . . 0.0 119.852 153.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -71.43 -8.05 51.28 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 162.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' A' ' 92' ' ' LEU . 3.0 m -112.24 -38.85 4.6 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -61.23 -22.43 64.79 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.52 -39.47 84.0 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.696 2.11 . . . . 0.0 116.696 163.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.6 m -92.18 -47.58 7.16 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 171.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -104.7 127.05 52.35 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 122.367 1.08 . . . . 0.0 111.455 -170.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -112.29 114.49 27.28 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 -165.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.26 -26.03 68.6 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.38 54.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.637 1.562 . . . . 0.0 113.937 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.02 24.67 15.15 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 121.422 3.329 . . . . 0.0 121.422 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -124.61 120.66 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.929 1.364 . . . . 0.0 109.795 -172.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.42 131.77 38.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.431 -0.793 . . . . 0.0 111.726 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.7 -93.77 0.21 Allowed Glycine 0 N--CA 1.491 2.343 0 CA-C-N 116.655 -0.248 . . . . 0.0 113.61 -170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.56 -57.82 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.515 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.87 159.13 16.75 Favored Glycine 0 CA--C 1.562 3.02 0 CA-C-N 118.78 0.718 . . . . 0.0 114.374 162.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.4 138.51 30.1 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.859 2.373 . . . . 0.0 114.521 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -50.04 113.37 0.84 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -75.42 -2.6 29.39 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.04 116.65 9.73 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 119.282 0.946 . . . . 0.0 110.387 162.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 24.46 39.78 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 118.606 2.202 . . . . 0.0 118.606 -168.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.38 -35.27 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 120.716 2.258 . . . . 0.0 116.98 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -73.04 114.86 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-N 121.02 1.736 . . . . 0.0 110.062 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.93 -8.96 79.08 Favored Glycine 0 CA--C 1.554 2.524 0 N-CA-C 118.813 2.285 . . . . 0.0 118.813 -163.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -83.09 147.3 28.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.325 2.063 . . . . 0.0 111.845 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 m -61.29 145.75 50.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.74 119.28 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 66.24 43.02 2.9 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -157.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.49 54.41 0.59 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 115.979 1.152 . . . . 0.0 115.979 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 80.1 t -133.23 115.45 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -72.55 118.94 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.0 111.473 169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.87 -52.97 0.81 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -162.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -83.06 135.73 34.74 Favored 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 118.09 0.945 . . . . 0.0 112.955 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -78.52 93.75 4.85 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.378 0.609 . . . . 0.0 111.641 173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -77.26 149.05 35.46 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 57.1 p -67.48 148.63 51.26 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -54.38 -45.26 99.37 Favored Pre-proline 0 CA--C 1.578 2.024 0 CA-C-O 116.15 -1.881 . . . . 0.0 115.827 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -63.13 -31.57 75.33 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 N-CA-C 118.863 2.601 . . . . 0.0 118.863 168.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.7 ttm -65.93 -41.73 90.97 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 164.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -61.9 -48.89 78.43 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.76 21.52 0.83 Allowed 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -79.83 -60.25 2.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.529 -1.357 . . . . 0.0 113.508 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.488 2.137 0 CA-C-N 118.918 0.781 . . . . 0.0 114.625 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.6 -176.83 44.69 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.408 1.004 . . . . 0.0 115.423 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -130.34 151.49 50.79 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.558 0.695 . . . . 0.0 110.496 172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -82.27 80.28 8.51 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.804 1.287 . . . . 0.0 113.577 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -79.12 159.64 72.64 Favored Pre-proline 0 CA--C 1.577 2.004 0 C-N-CA 124.492 1.117 . . . . 0.0 112.863 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -50.95 -46.87 28.29 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 123.006 2.471 . . . . 0.0 118.367 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.86 -53.56 55.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 167.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.58 -45.5 85.15 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.9 mt -57.88 -49.15 77.67 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 168.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.282 2.2 pp0? -62.64 -38.24 89.48 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 121.464 1.938 . . . . 0.0 115.989 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.85 -55.11 36.92 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -56.68 -45.59 81.64 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.43 -9.08 58.08 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -70.39 -55.89 7.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.798 1.636 . . . . 0.0 112.216 161.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -144.27 106.18 4.78 Favored Pre-proline 0 CA--C 1.576 1.958 0 CA-C-N 119.631 1.105 . . . . 0.0 109.078 168.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.44 -39.2 3.88 Favored 'Trans proline' 0 CA--C 1.559 1.762 0 N-CA-C 117.226 1.971 . . . . 0.0 117.226 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.66 -15.93 63.27 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.64 -48.22 19.76 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 161.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -70.51 -52.78 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-N 119.673 1.124 . . . . 0.0 113.493 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.77 97.56 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -74.63 102.2 4.49 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.529 0.681 . . . . 0.0 112.521 -170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.87 31.68 8.02 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.077 1.991 . . . . 0.0 118.077 -166.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.8 t -72.27 143.4 48.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 119.049 1.425 . . . . 0.0 113.101 165.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -75.47 10.37 1.71 Allowed 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 169.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.476 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttp -78.01 108.42 11.27 Favored 'General case' 0 CA--C 1.563 1.457 0 O-C-N 120.644 -1.285 . . . . 0.0 111.729 174.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.76 79.65 7.37 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 122.363 1.078 . . . . 0.0 112.369 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -145.04 127.65 16.12 Favored 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.91 -60.29 2.33 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 164.86 23.69 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 122.982 1.323 . . . . 0.0 115.952 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.4 mt -100.88 95.58 4.71 Favored Pre-proline 0 CA--C 1.575 1.932 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 163.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.11 -38.29 9.44 Favored 'Trans proline' 0 CA--C 1.565 2.035 0 C-N-CA 122.625 2.217 . . . . 0.0 117.655 -172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -78.06 123.85 27.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 119.179 0.899 . . . . 0.0 111.124 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -56.66 -28.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 166.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.31 -52.07 55.11 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -42.09 89.3 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 167.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.5 mtm-85 -58.43 -54.81 42.8 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.93 86.19 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 117.017 2.228 . . . . 0.0 117.017 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -54.88 -55.83 26.1 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 120.362 1.437 . . . . 0.0 114.67 166.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.424 HD11 ' SG ' ' A' ' 14' ' ' CYS . 7.2 tt -59.07 -45.5 90.66 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -64.38 -39.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.896 0 CA-C-N 119.794 1.179 . . . . 0.0 113.347 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.52 -43.78 68.6 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 161.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -61.13 -47.2 87.36 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 165.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.37 -36.16 70.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.13 -40.94 95.69 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 165.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.33 -37.09 94.03 Favored Glycine 0 CA--C 1.555 2.576 0 N-CA-C 118.437 2.135 . . . . 0.0 118.437 163.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.96 60.55 3.86 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 118.699 1.249 . . . . 0.0 111.707 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 C-N-CA 123.739 0.816 . . . . 0.0 112.04 -172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.597 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.34 71.17 0.76 Allowed 'General case' 0 CA--C 1.568 1.637 0 CA-C-N 120.054 1.297 . . . . 0.0 111.849 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.33 110.19 63.04 Favored Pre-proline 0 CA--C 1.572 1.793 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.892 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -68.2 -28.15 34.31 Favored 'Trans proline' 0 CA--C 1.566 2.085 0 N-CA-C 118.994 2.652 . . . . 0.0 118.994 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.2 -50.5 72.86 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 167.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.19 75.97 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 161.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.63 -37.56 50.82 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 119.505 2.562 . . . . 0.0 119.505 165.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -43.03 93.01 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 168.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.273 64.9 pttt -69.33 -36.87 77.36 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 168.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -58.85 -42.73 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 CA-C-N 120.492 1.496 . . . . 0.0 113.221 163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -59.04 -13.94 8.2 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.39 -41.47 4.04 Favored Glycine 0 CA--C 1.556 2.651 0 N-CA-C 119.192 2.437 . . . . 0.0 119.192 157.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.13 -35.87 81.73 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 165.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -79.84 -44.0 21.33 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.01 -23.18 44.42 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.642 3.201 . . . . 0.0 119.642 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.53 72.67 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.6 m -101.0 -35.72 9.27 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 172.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -117.22 133.12 56.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.831 1.252 . . . . 0.0 111.461 -166.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -96.61 138.22 34.52 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.564 -0.71 . . . . 0.0 112.839 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.07 2.71 48.82 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 165.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -110.95 52.1 0.75 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.49 1.495 . . . . 0.0 112.213 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.64 21.87 51.36 Favored Glycine 0 CA--C 1.556 2.654 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -117.22 141.99 47.6 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.143 1.472 . . . . 0.0 111.591 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -119.55 114.08 21.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.65 0.78 . . . . 0.0 109.014 -170.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.07 -98.48 0.96 Allowed Glycine 0 N--CA 1.492 2.384 0 O-C-N 121.844 -0.535 . . . . 0.0 113.679 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -74.19 -57.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.548 171.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.51 168.5 20.77 Favored Glycine 0 CA--C 1.562 2.998 0 CA-C-N 118.891 0.769 . . . . 0.0 114.832 158.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -69.53 177.54 5.32 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.739 2.292 . . . . 0.0 115.749 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -73.43 121.9 21.25 Favored 'General case' 0 CA--C 1.569 1.687 0 O-C-N 120.448 -1.408 . . . . 0.0 112.77 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.82 -4.16 59.14 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -62.34 120.66 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.998 1.272 . . . . 0.0 112.395 163.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.8 31.49 62.33 Favored Glycine 0 CA--C 1.551 2.325 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.34 -29.85 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.5 t -73.74 114.19 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 120.334 1.425 . . . . 0.0 109.964 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.53 -3.77 85.17 Favored Glycine 0 CA--C 1.554 2.469 0 N-CA-C 118.965 2.346 . . . . 0.0 118.965 -163.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -83.46 143.86 29.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.489 2.144 . . . . 0.0 112.199 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.1 m -58.09 145.6 36.06 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.46 122.21 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.857 0 O-C-N 121.379 -0.826 . . . . 0.0 109.483 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.283 . . 67.62 19.26 9.85 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -158.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.13 53.4 3.91 Favored Glycine 0 N--CA 1.488 2.106 0 O-C-N 119.952 -1.718 . . . . 0.0 116.775 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.97 105.93 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.86 95.91 3.6 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.58 0.705 . . . . 0.0 110.937 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.05 -45.51 0.58 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.42 -161.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -90.85 135.71 33.55 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 118.515 1.157 . . . . 0.0 111.372 171.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -80.33 97.33 6.97 Favored 'General case' 0 CA--C 1.567 1.63 0 O-C-N 121.75 -0.594 . . . . 0.0 111.435 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -80.72 156.45 26.25 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 25.5 p -68.53 147.63 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 113.559 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -51.14 -44.24 87.01 Favored Pre-proline 0 CA--C 1.578 2.032 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.39 -32.21 93.65 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 CA-C-N 124.596 2.677 . . . . 0.0 118.972 167.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.7 tpp -65.83 -43.56 88.18 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 164.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -63.42 -47.36 82.27 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 171.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.23 25.46 0.99 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -76.54 -57.41 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.432 -1.418 . . . . 0.0 114.058 177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 86.96 1.05 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.773 0.715 . . . . 0.0 114.53 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.94 -175.87 45.18 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-O 122.513 1.063 . . . . 0.0 115.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.21 152.01 51.6 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.685 0.755 . . . . 0.0 110.536 172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -82.16 74.59 9.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.816 1.293 . . . . 0.0 113.731 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.4 p -73.68 159.32 84.74 Favored Pre-proline 0 CA--C 1.577 1.992 0 C-N-CA 124.351 1.06 . . . . 0.0 112.998 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -49.81 -47.13 24.47 Favored 'Trans proline' 0 CA--C 1.565 2.032 0 C-N-CA 122.895 2.397 . . . . 0.0 118.007 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.38 -49.53 67.03 Favored 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.9 87.92 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.93 -48.16 78.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 168.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.297 2.7 pp0? -64.62 -37.2 86.74 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.81 -51.61 68.58 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 165.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -59.9 -41.89 92.63 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.36 -11.48 60.5 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.6 m -72.22 -57.67 4.04 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 120.754 1.616 . . . . 0.0 111.883 162.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -142.62 106.05 5.44 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 119.446 1.021 . . . . 0.0 108.647 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -71.25 -35.96 7.8 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 CA-C-N 122.271 1.847 . . . . 0.0 116.885 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.04 82.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.58 77.81 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 168.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.41 -52.71 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-N 119.548 1.067 . . . . 0.0 113.163 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.12 102.17 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -74.76 90.29 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 123.432 1.587 . . . . 0.0 114.176 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.13 41.9 3.64 Favored Glycine 0 CA--C 1.554 2.52 0 N-CA-C 116.726 1.45 . . . . 0.0 116.726 -163.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 t -75.06 131.75 40.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -1.005 . . . . 0.0 111.338 156.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -77.49 22.94 0.23 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 167.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' SD ' ' C4D' ' A' ' 101' ' ' HEC . 2.1 ttt -80.33 108.63 14.11 Favored 'General case' 0 CA--C 1.559 1.326 0 O-C-N 120.783 -1.198 . . . . 0.0 110.553 169.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.67 75.13 7.57 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 122.825 1.298 . . . . 0.0 112.954 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -142.48 127.34 18.25 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.63 -58.26 3.4 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.28 152.45 7.44 Favored Glycine 0 CA--C 1.543 1.812 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.42 100.83 7.55 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.761 -1.114 . . . . 0.0 108.33 163.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.72 -34.55 18.49 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 118.084 2.301 . . . . 0.0 118.084 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -76.67 125.56 29.46 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 119.446 1.021 . . . . 0.0 112.707 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.86 -45.14 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 166.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -56.98 -42.55 80.39 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -63.51 -41.31 98.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -59.67 -52.38 65.76 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 167.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.34 81.66 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 170.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -55.72 -52.31 64.34 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 120.352 1.433 . . . . 0.0 114.556 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -60.54 -43.52 97.08 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 72.8 mt -69.79 -32.06 50.66 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.046 0 CA-C-N 120.063 1.301 . . . . 0.0 113.876 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.6 77.23 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 155.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -62.06 -47.16 85.94 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.32 -36.92 71.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.39 -35.97 82.18 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.04 -42.77 92.15 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 117.699 1.839 . . . . 0.0 117.699 161.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 58.61 4.79 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 118.508 1.154 . . . . 0.0 112.123 174.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 N--CA 1.487 1.395 0 O-C-N 121.546 -0.721 . . . . 0.0 110.823 -167.065 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.648 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.7 ttp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 71.98 0.85 Allowed 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.937 0.875 . . . . 0.0 113.02 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -107.58 116.51 57.55 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.994 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.65 -23.01 20.08 Favored 'Trans proline' 0 CA--C 1.565 2.065 0 N-CA-C 118.576 2.491 . . . . 0.0 118.576 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.64 75.66 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 166.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.91 -36.98 78.15 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 160.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.59 -40.77 79.76 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 119.133 2.413 . . . . 0.0 119.133 166.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.43 -41.33 72.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 163.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.4 -48.25 82.08 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 168.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.26 -40.38 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 168.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -55.95 -18.47 9.26 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 166.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.83 -40.87 4.22 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 119.285 2.474 . . . . 0.0 119.285 156.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -63.4 -37.52 87.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 165.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.08 -41.26 20.8 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.53 -29.93 52.22 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 119.81 3.263 . . . . 0.0 119.81 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.75 -37.25 73.31 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 168.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.5 m -97.31 -43.81 7.16 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -106.13 131.84 52.91 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.754 1.222 . . . . 0.0 111.855 -168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -102.82 127.09 50.14 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.142 0.577 . . . . 0.0 110.689 -172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.35 -30.37 67.29 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 169.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.48 56.8 2.24 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 120.687 1.585 . . . . 0.0 113.771 176.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.35 32.83 30.72 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 121.682 3.433 . . . . 0.0 121.682 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -126.65 142.92 51.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.281 1.54 . . . . 0.0 112.639 -174.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.82 153.23 23.8 Favored 'General case' 0 CA--C 1.566 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 112.992 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.95 -84.52 0.05 OUTLIER Glycine 0 N--CA 1.49 2.3 0 O-C-N 121.786 -0.572 . . . . 0.0 112.706 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' HMD3 ' A' ' 101' ' ' HEC . 43.2 t -77.23 -63.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-O 119.032 -0.509 . . . . 0.0 109.722 162.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.31 141.3 15.24 Favored Glycine 0 CA--C 1.559 2.82 0 CA-C-O 118.558 -1.135 . . . . 0.0 114.428 172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.8 124.65 8.89 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 CA-C-N 121.734 2.767 . . . . 0.0 114.344 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -25.61 124.33 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 120.695 3.591 . . . . 0.0 120.695 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.46 -2.06 58.36 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.02 114.68 13.78 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.316 0.962 . . . . 0.0 110.056 163.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.83 43.59 14.16 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 -166.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.66 -38.17 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 172.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.4 115.06 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 120.513 1.506 . . . . 0.0 109.827 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.01 -2.85 84.37 Favored Glycine 0 CA--C 1.553 2.426 0 N-CA-C 119.077 2.391 . . . . 0.0 119.077 -164.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -80.11 143.83 33.61 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 120.85 2.325 . . . . 0.0 111.929 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -57.86 142.56 45.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.19 122.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.898 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.312 . . 67.91 30.64 6.06 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -159.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -99.87 49.77 1.15 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 117.481 1.752 . . . . 0.0 117.481 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.3 t -128.95 105.53 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 167.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -73.55 100.65 3.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.742 -0.599 . . . . 0.0 109.996 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.12 -30.52 2.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 116.821 1.488 . . . . 0.0 116.821 -157.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -108.22 138.86 43.78 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 119.754 1.777 . . . . 0.0 111.727 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.07 94.85 6.68 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-O 121.586 0.708 . . . . 0.0 111.394 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -76.92 153.32 34.79 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -70.44 148.11 48.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.99 -1.069 . . . . 0.0 113.014 171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.09 -43.8 77.87 Favored Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.02 -33.33 92.19 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 CA-C-N 124.532 2.654 . . . . 0.0 118.865 167.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 tpp -67.57 -41.61 83.9 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 165.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.62 -48.69 73.94 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.44 30.76 0.69 Allowed 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.24 -59.67 2.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.502 -1.373 . . . . 0.0 113.885 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.52 87.19 1.04 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 118.736 0.698 . . . . 0.0 114.516 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.97 -176.35 43.76 Favored Glycine 0 CA--C 1.545 1.915 0 CA-C-O 122.577 1.098 . . . . 0.0 115.657 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -130.75 153.54 48.92 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.918 0.866 . . . . 0.0 110.472 173.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -81.63 79.02 8.3 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.644 1.211 . . . . 0.0 113.275 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 p -75.22 161.25 77.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 C-N-CA 124.347 1.059 . . . . 0.0 113.386 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -48.94 -49.08 16.01 Favored 'Trans proline' 0 CA--C 1.561 1.856 0 C-N-CA 123.048 2.499 . . . . 0.0 118.056 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.32 6.7 pt-20 -58.98 -50.04 75.6 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 168.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.4 mt -58.71 -50.85 72.35 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 166.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.284 2.6 pp0? -64.85 -36.14 83.39 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 121.922 2.146 . . . . 0.0 116.278 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -60.55 -51.89 67.52 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 165.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.36 -46.54 89.58 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.45 -11.67 61.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -69.21 -54.88 12.52 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.144 1.338 . . . . 0.0 112.588 159.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -145.22 104.4 4.38 Favored Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.574 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -58.56 -41.67 62.21 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 N-CA-C 118.436 2.437 . . . . 0.0 118.436 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -34.86 78.59 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.7 -43.17 90.01 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.7 t -76.46 -51.9 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.306 0.957 . . . . 0.0 112.719 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.19 99.51 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -79.89 94.86 5.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.309 1.052 . . . . 0.0 112.492 -169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.65 43.89 3.04 Favored Glycine 0 CA--C 1.554 2.479 0 N-CA-C 116.495 1.358 . . . . 0.0 116.495 -163.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.21 138.53 38.7 Favored 'General case' 0 CA--C 1.566 1.572 0 O-C-N 121.646 -0.914 . . . . 0.0 112.156 162.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -75.37 12.3 1.0 Allowed 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttt -79.73 113.09 17.62 Favored 'General case' 0 CA--C 1.561 1.366 0 O-C-N 120.559 -1.338 . . . . 0.0 111.683 177.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.16 73.58 8.19 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-O 122.808 1.29 . . . . 0.0 113.327 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -143.68 125.75 15.41 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.96 -56.32 4.87 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.93 150.59 6.36 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 115.566 0.986 . . . . 0.0 115.566 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.4 mt -97.49 102.34 12.59 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.752 -1.118 . . . . 0.0 108.727 166.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.33 -35.06 11.61 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 C-N-CA 122.645 2.23 . . . . 0.0 117.889 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.31 128.19 33.26 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.368 0.985 . . . . 0.0 112.034 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -43.29 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 167.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.22 -46.78 75.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.51 -43.92 84.63 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 168.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -63.21 -51.6 65.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.95 90.6 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -56.94 -51.74 67.96 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 120.462 1.483 . . . . 0.0 114.079 166.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.426 HD21 HMB1 ' A' ' 101' ' ' HEC . 46.4 tp -55.62 -46.85 77.32 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 168.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.264 68.5 mt -69.73 -28.84 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 119.902 1.228 . . . . 0.0 114.294 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.84 80.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 121.532 1.969 . . . . 0.0 115.662 156.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -61.78 -47.51 84.82 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.06 -31.57 72.0 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.3 -35.24 80.4 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 162.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.26 99.42 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 117.743 1.857 . . . . 0.0 117.743 160.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -90.49 62.16 5.17 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 118.253 1.026 . . . . 0.0 112.103 171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 124.13 0.972 . . . . 0.0 110.874 -173.415 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.672 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.29 72.34 0.78 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.632 0.729 . . . . 0.0 112.846 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -108.06 114.5 59.72 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.976 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -72.35 -23.37 20.69 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 N-CA-C 118.703 2.54 . . . . 0.0 118.703 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.21 80.01 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 167.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.92 88.05 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 158.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.35 -40.28 67.91 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 119.606 2.602 . . . . 0.0 119.606 168.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -55.08 -47.8 74.4 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.147 1.473 . . . . 0.0 114.803 165.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.54 -44.69 96.59 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 170.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.01 -41.24 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 119.869 1.213 . . . . 0.0 113.7 166.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.38 -15.28 6.16 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.19 -39.5 5.39 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.409 2.524 . . . . 0.0 119.409 153.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.61 -9.12 56.16 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 166.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.5 -39.76 5.54 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -57.8 -26.38 61.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 119.853 3.279 . . . . 0.0 119.853 -171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.78 72.61 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.6 m -95.22 -42.79 8.38 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 168.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -107.44 134.18 50.87 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 122.761 1.267 . . . . 0.0 112.425 -166.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -100.22 134.69 42.78 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.126 -175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.6 mt -83.3 -19.56 36.04 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.59 50.35 1.47 Allowed 'General case' 0 N--CA 1.5 2.038 0 CA-C-N 121.6 2.0 . . . . 0.0 114.63 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.09 14.49 4.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 122.277 3.671 . . . . 0.0 122.277 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -138.52 126.84 23.0 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 119.066 1.433 . . . . 0.0 109.001 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -74.55 151.01 39.51 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.72 -104.66 0.64 Allowed Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.14 -0.35 . . . . 0.0 112.746 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.39 -52.12 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.261 170.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 167.35 17.21 Favored Glycine 0 CA--C 1.565 3.177 0 N-CA-C 115.342 0.897 . . . . 0.0 115.342 161.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.21 138.42 33.27 Favored 'Trans proline' 0 CA--C 1.562 1.882 0 C-N-CA 123.411 2.741 . . . . 0.0 113.859 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -52.4 123.57 11.22 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.8 2.11 50.02 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -80.53 118.56 22.23 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 119.854 1.206 . . . . 0.0 109.533 161.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.07 40.34 14.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 -167.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -97.32 -33.82 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.42 114.24 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.798 1.635 . . . . 0.0 109.941 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.63 -2.86 84.93 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 119.068 2.387 . . . . 0.0 119.068 -164.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -80.49 144.02 32.87 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.671 2.235 . . . . 0.0 111.907 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.0 m -57.27 143.11 40.8 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.2 t -68.98 121.47 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.888 0 O-C-N 121.531 -0.73 . . . . 0.0 109.381 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.42 25.29 5.5 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -160.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.2 49.48 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 117.597 1.799 . . . . 0.0 117.597 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.1 t -127.25 104.35 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 167.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.91 99.84 3.35 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.362 0.601 . . . . 0.0 109.873 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.22 -26.96 2.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 117.085 1.594 . . . . 0.0 117.085 -156.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -108.26 138.3 44.78 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 120.003 1.901 . . . . 0.0 111.687 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -81.13 89.73 6.0 Favored 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.537 0.684 . . . . 0.0 111.757 172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -75.79 154.51 36.2 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 p -71.07 146.66 49.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.042 -1.036 . . . . 0.0 113.213 167.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -51.54 -42.87 85.3 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.84 -32.75 97.83 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 N-CA-C 119.09 2.688 . . . . 0.0 119.09 166.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.1 tpp -67.39 -42.49 83.27 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 164.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -64.38 -46.77 81.91 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 173.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 25.86 0.92 Allowed 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -77.68 -59.17 2.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.484 -1.385 . . . . 0.0 113.773 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 89.67 1.03 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 118.871 0.76 . . . . 0.0 114.606 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.76 -174.82 44.02 Favored Glycine 0 CA--C 1.545 1.94 0 CA-C-O 122.415 1.008 . . . . 0.0 115.581 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.51 152.54 50.65 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.941 0.877 . . . . 0.0 110.507 173.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -82.23 78.26 8.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.704 1.24 . . . . 0.0 113.365 -173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 76.5 p -74.81 159.07 83.91 Favored Pre-proline 0 CA--C 1.576 1.962 0 C-N-CA 124.254 1.022 . . . . 0.0 113.086 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -50.91 -46.4 30.8 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 122.908 2.406 . . . . 0.0 117.926 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.251 12.6 pt-20 -54.17 -52.39 61.34 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 165.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.67 98.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 172.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 mt -56.9 -49.64 74.94 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 167.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.288 2.4 pp0? -65.2 -35.08 79.95 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.23 -53.99 51.09 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 164.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -59.3 -42.01 90.31 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.66 -14.14 61.52 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.7 m -69.88 -58.71 3.55 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.959 1.709 . . . . 0.0 111.876 163.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -141.05 105.55 6.16 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.293 0.951 . . . . 0.0 108.842 170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.01 -36.26 10.45 Favored 'Trans proline' 0 CA--C 1.562 1.896 0 C-N-CA 122.109 1.873 . . . . 0.0 116.961 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.88 -32.88 74.64 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -44.63 73.18 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 167.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.3 t -71.23 -50.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 119.376 0.989 . . . . 0.0 113.397 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.2 101.9 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -77.02 96.07 4.32 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.918 0.866 . . . . 0.0 112.772 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.07 42.15 4.42 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -162.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.8 t -74.75 133.55 41.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.55 -0.971 . . . . 0.0 111.825 161.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 24.91 0.08 Allowed 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 117.371 2.359 . . . . 0.0 117.371 168.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.433 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -90.66 110.78 21.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.899 -1.126 . . . . 0.0 110.479 172.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.02 75.37 8.0 Favored 'General case' 0 CA--C 1.568 1.635 0 CA-C-O 122.585 1.183 . . . . 0.0 113.034 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -145.71 128.03 15.85 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.9 -55.12 6.57 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.56 157.48 9.29 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.409 1.005 . . . . 0.0 115.133 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.8 mt -97.72 98.66 5.5 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 164.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -33.24 20.36 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.639 2.226 . . . . 0.0 117.682 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.97 125.08 28.44 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 119.136 0.88 . . . . 0.0 112.199 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -49.87 -42.29 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 163.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -52.32 -46.99 66.22 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 170.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.63 -45.67 93.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 168.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -60.69 -53.87 52.18 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 173.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.78 -40.1 91.34 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -59.8 -51.21 70.73 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.231 1.378 . . . . 0.0 114.002 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -57.96 -44.94 87.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.26 78.0 mt -65.76 -36.98 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.106 1.321 . . . . 0.0 113.6 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.08 -44.16 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 159.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -62.66 -43.85 97.76 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 167.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.6 mt -59.85 -36.31 76.59 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.55 -38.3 89.5 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.63 -4.19 60.71 Favored Glycine 0 CA--C 1.56 2.856 0 N-CA-C 119.924 2.73 . . . . 0.0 119.924 160.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -123.92 71.48 1.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.458 1.629 . . . . 0.0 108.419 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.255 1.365 0 O-C-N 121.629 -0.669 . . . . 0.0 110.589 -161.519 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.605 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 CA--C 1.561 1.398 0 CA-C-O 120.873 0.368 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.259 . . 57.75 42.89 22.83 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 118.782 2.882 . . . . 0.0 118.782 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -102.13 113.2 65.95 Favored Pre-proline 0 CA--C 1.574 1.891 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.355 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.31 -23.46 24.09 Favored 'Trans proline' 0 CA--C 1.566 2.084 0 N-CA-C 118.69 2.535 . . . . 0.0 118.69 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.85 -48.78 75.39 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.46 81.88 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 160.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.4 -40.46 68.85 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 119.585 2.594 . . . . 0.0 119.585 167.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -53.81 -46.01 70.97 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 163.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -58.84 -46.92 86.57 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.47 -39.69 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 CA-C-N 119.88 1.218 . . . . 0.0 113.868 170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -53.69 -20.2 5.09 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 164.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.66 -37.55 2.76 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 119.826 2.691 . . . . 0.0 119.826 157.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -67.98 -31.93 71.98 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.28 -41.06 22.73 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -54.71 -31.23 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 119.601 3.186 . . . . 0.0 119.601 -171.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.63 -37.17 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 168.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -93.83 -43.14 8.74 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 169.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -109.24 129.16 55.51 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-O 122.493 1.139 . . . . 0.0 111.582 -168.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -97.43 134.79 40.21 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.877 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.72 -24.55 41.56 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 169.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.73 53.98 1.73 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 121.028 1.74 . . . . 0.0 114.638 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.8 12.1 6.42 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 122.558 3.783 . . . . 0.0 122.558 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -135.95 126.79 27.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.287 1.543 . . . . 0.0 109.295 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.93 136.03 45.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.9 -113.99 2.86 Favored Glycine 0 N--CA 1.491 2.328 0 CA-C-O 120.113 -0.27 . . . . 0.0 113.303 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.65 -45.43 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 117.465 0.632 . . . . 0.0 111.985 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.31 165.64 17.07 Favored Glycine 0 CA--C 1.565 3.156 0 CA-C-N 119.263 0.938 . . . . 0.0 114.808 156.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.69 144.02 47.91 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 123.011 2.474 . . . . 0.0 114.577 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -54.23 118.17 3.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -171.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.83 0.41 27.21 Favored 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -76.1 116.09 16.46 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 119.684 1.129 . . . . 0.0 110.111 166.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.97 35.1 16.39 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -167.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -90.36 -34.4 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.01 116.94 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 121.222 1.828 . . . . 0.0 109.693 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.33 1.49 83.85 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 -163.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -79.35 142.52 35.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.946 1.873 . . . . 0.0 111.948 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.2 m -55.5 139.1 44.88 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.7 115.79 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.284 . . 70.64 69.05 0.19 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -156.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.83 55.61 0.74 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.5 t -141.31 112.33 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.01 105.22 5.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.741 -0.599 . . . . 0.0 110.402 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.31 -49.38 0.8 Allowed Glycine 0 N--CA 1.49 2.252 0 CA-C-O 119.418 -0.657 . . . . 0.0 114.672 -158.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -86.47 133.85 33.73 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 118.278 1.039 . . . . 0.0 112.16 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -80.01 99.55 7.71 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 121.743 -0.598 . . . . 0.0 111.056 172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -81.62 155.16 25.78 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.3 p -70.76 145.82 50.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.915 -1.116 . . . . 0.0 113.038 169.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -50.5 -44.92 84.34 Favored Pre-proline 0 CA--C 1.579 2.063 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.17 -33.27 98.19 Favored 'Trans proline' 0 CA--C 1.561 1.832 0 N-CA-C 119.052 2.674 . . . . 0.0 119.052 167.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.3 tpp -66.14 -42.82 88.56 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 165.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.5 -46.35 80.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.42 23.45 0.92 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 170.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.38 -58.4 3.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.45 -1.406 . . . . 0.0 113.794 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 88.11 0.97 Allowed Glycine 0 N--CA 1.488 2.143 0 CA-C-N 118.787 0.722 . . . . 0.0 114.666 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -176.39 45.08 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.559 1.088 . . . . 0.0 115.518 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -129.59 153.01 48.49 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.069 0.937 . . . . 0.0 110.61 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -82.01 80.36 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.872 1.32 . . . . 0.0 113.068 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -76.94 159.48 78.52 Favored Pre-proline 0 CA--C 1.576 1.954 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.748 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -50.8 -46.93 27.61 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 122.786 2.324 . . . . 0.0 117.563 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.259 12.6 pt-20 -51.08 -52.95 38.44 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.041 2.238 . . . . 0.0 117.041 165.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.65 98.33 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 172.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.4 mt -58.68 -48.44 81.08 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 170.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -64.5 -34.87 79.22 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.5 -54.97 39.03 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 164.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.42 -42.39 91.74 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.86 -14.36 61.48 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -69.47 -56.32 7.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 120.697 1.589 . . . . 0.0 112.356 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -144.0 105.55 4.86 Favored Pre-proline 0 CA--C 1.574 1.89 0 CA-C-N 119.757 1.162 . . . . 0.0 109.042 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.76 -38.32 4.35 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 N-CA-C 117.071 1.912 . . . . 0.0 117.071 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.04 -20.7 62.35 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -46.22 56.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -70.04 -50.84 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-N 119.45 1.023 . . . . 0.0 113.548 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.91 100.36 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.43 99.82 4.29 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.655 0.74 . . . . 0.0 112.317 -172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.73 41.59 5.32 Favored Glycine 0 CA--C 1.554 2.531 0 N-CA-C 117.053 1.581 . . . . 0.0 117.053 -163.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -75.84 136.9 40.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.48 -1.012 . . . . 0.0 111.589 159.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -69.45 5.76 1.26 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 166.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.461 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -76.47 108.4 9.41 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 120.027 1.285 . . . . 0.0 112.106 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.22 80.21 6.68 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 122.443 1.116 . . . . 0.0 112.235 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -145.83 126.96 14.69 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.15 -59.81 2.58 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 167.62 152.55 7.56 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -97.49 100.37 7.99 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.375 164.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 -33.53 11.55 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 N-CA-C 117.942 2.247 . . . . 0.0 117.942 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -79.43 128.28 33.15 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.352 0.978 . . . . 0.0 111.893 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.49 -43.63 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 167.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -55.86 -47.16 77.81 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.15 -43.95 82.99 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 168.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -61.99 -54.29 43.71 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 170.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.09 -44.08 87.4 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -56.65 -51.42 68.79 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.78 -47.06 86.03 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 171.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.9 mt -61.21 -39.56 82.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.972 1.26 . . . . 0.0 114.194 173.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.64 -43.08 68.45 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 161.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -63.4 -42.86 98.78 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 167.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.34 -34.65 74.14 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 167.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -65.15 -37.34 87.09 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 164.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.51 -43.24 99.31 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 161.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -88.86 62.13 6.24 Favored 'General case' 0 CA--C 1.573 1.833 0 C-N-CA 124.164 0.986 . . . . 0.0 112.083 171.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 124.023 0.929 . . . . 0.0 110.758 -173.335 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.6 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.49 75.15 1.3 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 112.888 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.76 105.05 50.42 Favored Pre-proline 0 CA--C 1.573 1.84 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.211 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -59.58 -32.22 95.71 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 N-CA-C 119.817 2.968 . . . . 0.0 119.817 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -51.16 65.2 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.6 -37.19 75.3 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 162.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.93 78.98 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 118.756 2.263 . . . . 0.0 118.756 165.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.92 -46.8 81.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 119.381 1.59 . . . . 0.0 114.688 165.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -56.12 -47.6 77.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 170.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.96 -42.68 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -59.62 -12.17 6.25 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -46.49 -40.14 10.96 Favored Glycine 0 CA--C 1.553 2.467 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 157.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.84 -35.01 75.45 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 163.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.6 m -81.82 -42.81 19.15 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.277 56.8 pttt -62.27 -20.88 64.73 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 120.046 3.35 . . . . 0.0 120.046 -169.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.43 84.79 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 160.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.1 m -92.11 -43.16 9.52 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.826 1.788 . . . . 0.0 115.826 172.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -116.59 123.52 47.54 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.644 1.111 . . . . 0.0 111.129 -168.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -113.18 117.16 31.13 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.342 1.068 . . . . 0.0 111.741 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.55 -3.73 26.38 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.3 56.4 3.37 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.902 1.683 . . . . 0.0 112.363 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.62 32.88 17.33 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 121.042 3.177 . . . . 0.0 121.042 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -136.74 146.15 45.47 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.639 1.219 . . . . 0.0 111.715 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -87.54 136.94 32.74 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 171.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.4 -98.54 2.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.2 t -84.03 -47.59 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 118.942 -0.552 . . . . 0.0 110.917 161.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.47 176.96 31.76 Favored Glycine 0 CA--C 1.56 2.871 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 166.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.23 176.71 4.41 Favored 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 122.93 2.42 . . . . 0.0 116.23 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -73.48 120.17 18.72 Favored 'General case' 0 CA--C 1.566 1.586 0 O-C-N 120.252 -1.53 . . . . 0.0 112.274 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -85.26 0.32 52.3 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 177.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.28 112.56 5.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 120.158 1.345 . . . . 0.0 111.689 171.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.75 39.8 19.85 Favored Glycine 0 CA--C 1.549 2.168 0 N-CA-C 116.708 1.443 . . . . 0.0 116.708 -167.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.16 -30.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 174.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.8 t -69.68 111.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 120.557 1.526 . . . . 0.0 109.968 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -5.25 74.61 Favored Glycine 0 CA--C 1.556 2.602 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 -163.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -84.6 143.18 29.44 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 120.22 2.01 . . . . 0.0 112.45 -174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -54.3 141.56 29.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.85 128.28 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.285 0.634 . . . . 0.0 110.211 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 66.37 24.23 10.54 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.855 2.539 . . . . 0.0 117.855 -160.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 49.62 4.03 Favored Glycine 0 N--CA 1.488 2.156 0 O-C-N 119.937 -1.727 . . . . 0.0 117.048 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.18 98.53 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -73.97 101.61 3.88 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.431 0.634 . . . . 0.0 110.517 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.48 -49.02 0.75 Allowed Glycine 0 N--CA 1.488 2.128 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.438 -157.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -79.67 136.3 36.77 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-N 118.614 1.207 . . . . 0.0 111.951 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -79.32 88.9 4.94 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.555 0.693 . . . . 0.0 112.132 175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -76.95 155.61 32.59 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 p -69.21 146.7 52.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.84 -1.163 . . . . 0.0 113.308 167.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -51.12 -43.48 85.09 Favored Pre-proline 0 CA--C 1.577 2.002 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -59.65 -32.04 95.25 Favored 'Trans proline' 0 CA--C 1.56 1.802 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 167.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.9 tpp -67.54 -43.27 81.14 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 164.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.09 -48.37 78.91 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.57 32.76 0.77 Allowed 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -77.58 -58.53 3.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.492 -1.38 . . . . 0.0 113.698 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.19 86.76 1.18 Allowed Glycine 0 N--CA 1.487 2.064 0 CA-C-N 118.678 0.672 . . . . 0.0 114.487 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.55 -178.35 43.23 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-O 122.626 1.126 . . . . 0.0 115.568 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -130.64 150.0 52.04 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.983 0.897 . . . . 0.0 110.279 173.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.11 73.97 8.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.887 1.327 . . . . 0.0 113.586 -171.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.1 p -70.74 157.11 90.94 Favored Pre-proline 0 CA--C 1.578 2.036 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.871 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -50.1 -47.27 24.53 Favored 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 122.949 2.433 . . . . 0.0 117.832 175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -49.19 -54.61 15.69 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 163.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.64 -43.1 97.8 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.9 mt -57.98 -50.06 74.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.285 3.2 pp0? -64.43 -34.87 79.19 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.76 -53.19 60.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 163.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.3 -42.01 94.62 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.43 -14.42 61.69 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.1 m -69.59 -57.53 5.07 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.654 1.57 . . . . 0.0 112.127 162.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -142.18 106.26 5.66 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-N 119.452 1.024 . . . . 0.0 108.708 170.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -70.3 -35.04 11.72 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 N-CA-C 117.297 1.999 . . . . 0.0 117.297 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -66.36 -32.56 74.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.22 -44.36 84.02 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -73.9 -50.81 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 119.279 0.945 . . . . 0.0 113.158 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.94 100.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -76.83 100.96 5.68 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.709 0.766 . . . . 0.0 112.308 -173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.38 42.74 4.8 Favored Glycine 0 CA--C 1.554 2.485 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -163.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -78.85 133.34 37.01 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.719 -0.871 . . . . 0.0 111.768 164.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.72 25.59 0.09 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 167.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.43 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -92.69 111.05 22.51 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 120.923 -1.111 . . . . 0.0 110.215 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.63 77.94 7.41 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.524 1.154 . . . . 0.0 112.688 172.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -143.59 132.1 22.29 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 124.162 0.985 . . . . 0.0 108.667 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 -61.57 1.97 Allowed 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.47 149.43 6.16 Favored Glycine 0 CA--C 1.544 1.884 0 N-CA-C 115.676 1.03 . . . . 0.0 115.676 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.9 mt -98.74 102.2 14.25 Favored Pre-proline 0 CA--C 1.574 1.881 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.082 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.43 -32.63 15.44 Favored 'Trans proline' 0 CA--C 1.566 2.079 0 N-CA-C 118.161 2.331 . . . . 0.0 118.161 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.67 124.44 28.56 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 119.56 1.073 . . . . 0.0 111.955 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.21 -44.76 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 166.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -53.49 -47.93 69.39 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.26 -44.42 92.4 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -60.59 -53.44 57.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.72 88.26 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 172.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.88 -48.37 81.65 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 120.168 1.349 . . . . 0.0 114.278 168.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -56.73 -45.9 81.65 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.88 -42.52 95.07 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.008 0 CA-C-N 119.52 1.055 . . . . 0.0 113.285 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -42.79 74.26 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 163.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -55.91 -50.42 70.75 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 162.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.63 -34.12 70.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.159 2.281 . . . . 0.0 117.159 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.87 -33.52 76.19 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 165.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.47 83.34 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.574 1.79 . . . . 0.0 117.574 159.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -88.3 66.84 8.54 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.603 1.192 . . . . 0.0 111.585 177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 . . . . . 0 N--CA 1.486 1.349 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.009 178.339 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.607 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 CA--C 1.559 1.3 0 CA-C-O 121.344 0.592 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.286 . . 61.02 37.05 18.28 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 119.036 2.976 . . . . 0.0 119.036 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -102.03 110.99 63.73 Favored Pre-proline 0 CA--C 1.575 1.938 0 O-C-N 121.095 -1.003 . . . . 0.0 109.938 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.87 -25.59 23.28 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.514 2.467 . . . . 0.0 118.514 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.8 -48.57 78.52 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 166.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.73 87.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 161.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.81 -36.56 50.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 166.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.77 87.36 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 168.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.257 65.1 pttt -68.37 -37.63 80.62 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 169.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -59.74 -41.37 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 CA-C-N 120.22 1.373 . . . . 0.0 113.589 165.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -59.86 -12.5 7.7 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 167.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.64 -38.93 7.72 Favored Glycine 0 CA--C 1.556 2.64 0 N-CA-C 119.207 2.443 . . . . 0.0 119.207 153.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -69.61 -11.93 61.23 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 117.55 2.426 . . . . 0.0 117.55 165.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -103.96 -39.54 6.55 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -56.3 -28.63 59.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -169.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.59 -38.1 77.21 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 167.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.3 m -93.03 -40.65 10.41 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 170.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.16 131.38 56.46 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.49 1.116 . . . . 0.0 111.443 -168.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -112.61 118.78 36.03 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.36 -32.6 74.33 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.42 61.56 4.94 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.144 1.338 . . . . 0.0 113.035 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.76 33.31 55.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.541 3.376 . . . . 0.0 121.541 172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -120.97 108.83 14.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.229 1.514 . . . . 0.0 110.63 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -91.54 121.76 33.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 111.762 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.97 -93.32 0.26 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 123.197 0.311 . . . . 0.0 113.403 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.87 -57.22 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.413 167.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.17 162.19 16.12 Favored Glycine 0 CA--C 1.564 3.116 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.83 146.14 47.33 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.25 2.634 . . . . 0.0 115.026 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -58.83 117.25 4.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.94 17.05 3.03 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 -170.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -64.58 111.12 2.57 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.651 -1.28 . . . . 0.0 114.028 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.14 40.24 98.93 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 -169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.28 5.1 p -69.6 -23.4 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.3 109.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.146 1.339 . . . . 0.0 109.923 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.16 -3.0 76.02 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 -165.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -96.37 153.35 17.87 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 120.251 2.025 . . . . 0.0 112.176 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.2 m -57.73 142.01 46.75 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.7 118.75 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 170.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.0 61.6 0.5 Allowed 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -154.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.05 57.83 0.67 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 115.714 1.046 . . . . 0.0 115.714 -173.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.5 t -141.7 114.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 161.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -76.13 104.03 6.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.631 -0.668 . . . . 0.0 109.913 169.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.92 -48.56 0.79 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 114.756 0.662 . . . . 0.0 114.756 -159.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -87.62 133.18 33.85 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 118.315 1.057 . . . . 0.0 111.967 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -81.08 96.31 7.12 Favored 'General case' 0 CA--C 1.567 1.603 0 O-C-N 121.748 -0.595 . . . . 0.0 111.165 172.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -75.24 157.69 34.09 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.5 p -68.0 136.14 53.41 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 167.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -50.75 -43.04 81.25 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.9 -28.65 83.51 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 N-CA-C 119.627 2.895 . . . . 0.0 119.627 167.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.6 tpp -68.52 -44.81 73.81 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 163.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -65.23 -45.09 86.07 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.85 9.15 2.52 Favored 'General case' 0 CA--C 1.574 1.898 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -72.77 -58.27 3.47 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-N 120.455 1.48 . . . . 0.0 113.672 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.16 88.93 0.73 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 115.075 0.79 . . . . 0.0 115.075 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.81 -171.39 44.36 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.725 1.181 . . . . 0.0 115.835 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -126.72 152.0 47.4 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.252 1.025 . . . . 0.0 110.338 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 35.3 m95 -81.33 77.4 8.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.492 1.139 . . . . 0.0 113.359 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -69.21 157.4 89.41 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.974 0.909 . . . . 0.0 113.381 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.22 -47.24 26.79 Favored 'Trans proline' 0 CA--C 1.565 2.052 0 C-N-CA 122.823 2.348 . . . . 0.0 117.682 174.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.99 -51.92 60.0 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 165.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.3 96.53 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 172.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.56 -49.06 78.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 168.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.296 2.8 pp0? -63.06 -36.05 82.27 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.86 -54.97 38.65 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 164.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.77 -43.14 85.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 173.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.52 -11.28 60.39 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -72.33 -56.79 4.9 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.768 1.622 . . . . 0.0 112.07 161.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -141.48 104.74 5.94 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-N 119.672 1.123 . . . . 0.0 109.213 170.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -73.28 -33.16 7.47 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 N-CA-C 117.247 1.98 . . . . 0.0 117.247 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.25 77.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 170.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.05 67.74 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.9 t -72.74 -48.7 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.434 1.015 . . . . 0.0 113.685 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.65 98.61 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -76.37 102.61 6.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.535 0.684 . . . . 0.0 112.58 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.48 35.43 5.95 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 -165.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.62 144.78 37.2 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.389 1.095 . . . . 0.0 113.118 168.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -70.04 -2.8 13.79 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.417 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -73.85 106.38 5.54 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-N 120.912 1.687 . . . . 0.0 112.725 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.51 76.08 9.39 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 122.579 1.181 . . . . 0.0 112.628 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -138.58 127.78 24.22 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.09 -61.06 1.99 Allowed 'General case' 0 CA--C 1.563 1.453 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.92 156.77 11.87 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -95.81 101.66 8.63 Favored Pre-proline 0 CA--C 1.576 1.955 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.7 -33.58 12.79 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 N-CA-C 118.201 2.346 . . . . 0.0 118.201 -173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.52 127.48 33.36 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 119.495 1.043 . . . . 0.0 112.175 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.52 -45.07 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.81 -47.42 70.87 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 170.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.44 -44.47 89.19 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -59.44 -53.43 58.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.64 -43.37 84.85 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 170.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -55.22 -50.17 70.1 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.53 -43.25 89.15 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.85 -43.85 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.996 0 CA-C-N 119.556 1.071 . . . . 0.0 113.437 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 161.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.16 -45.84 91.71 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.68 -36.98 75.06 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 168.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.86 -39.85 94.2 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 166.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.04 -41.85 99.7 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 117.815 1.886 . . . . 0.0 117.815 162.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -88.81 62.56 6.46 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.658 1.183 . . . . 0.0 112.434 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 N--CA 1.486 1.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.48 171.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.625 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 CA--C 1.565 1.53 0 CA-C-O 118.986 -0.53 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.13 105.21 0.66 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.167 1.349 . . . . 0.0 110.718 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -145.41 102.63 4.33 Favored Pre-proline 0 CA--C 1.573 1.845 0 O-C-N 121.107 -0.996 . . . . 0.0 110.124 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.75 -34.28 91.94 Favored 'Trans proline' 0 CA--C 1.563 1.937 0 N-CA-C 119.607 2.887 . . . . 0.0 119.607 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.52 -50.68 68.61 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.48 -34.7 74.43 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 162.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.24 -42.17 81.48 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.687 2.235 . . . . 0.0 118.687 164.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -41.72 78.21 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 163.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -61.4 -48.36 81.55 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.5 t -59.09 -42.17 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 168.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -58.4 -14.42 7.61 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 167.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -42.31 -41.27 3.89 Favored Glycine 0 CA--C 1.557 2.659 0 N-CA-C 119.109 2.404 . . . . 0.0 119.109 156.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.43 -37.23 86.49 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 165.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.89 -43.25 25.3 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -57.64 -23.48 51.43 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.11 -34.91 68.84 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 162.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -104.02 -37.91 7.17 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 172.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -113.77 131.08 56.35 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.762 1.225 . . . . 0.0 111.634 -167.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -105.56 126.19 51.85 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.58 0.705 . . . . 0.0 112.574 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.6 mt -80.27 -12.09 59.65 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.48 58.12 2.35 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 121.091 1.769 . . . . 0.0 112.23 169.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.94 33.37 50.24 Favored Glycine 0 CA--C 1.555 2.578 0 N-CA-C 121.019 3.167 . . . . 0.0 121.019 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -117.86 139.29 51.32 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.907 1.353 . . . . 0.0 111.766 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -119.38 112.36 19.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.78 -95.25 0.54 Allowed Glycine 0 N--CA 1.491 2.356 0 O-C-N 121.847 -0.533 . . . . 0.0 113.464 -172.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.78 -58.25 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.452 170.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.4 167.01 16.34 Favored Glycine 0 CA--C 1.564 3.131 0 CA-C-N 118.997 0.817 . . . . 0.0 115.07 160.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.05 172.36 13.06 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 122.978 2.452 . . . . 0.0 116.09 174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.48 109.6 8.1 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 120.707 -1.245 . . . . 0.0 113.214 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.22 -6.16 50.14 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -61.54 120.84 11.33 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-N 119.952 1.251 . . . . 0.0 112.489 162.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.53 22.86 66.25 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 119.046 2.378 . . . . 0.0 119.046 -171.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.65 -32.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.6 t -71.84 116.49 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 120.404 1.456 . . . . 0.0 110.248 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -6.06 84.01 Favored Glycine 0 CA--C 1.554 2.477 0 N-CA-C 119.121 2.408 . . . . 0.0 119.121 -165.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -88.37 149.1 23.91 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 120.386 2.093 . . . . 0.0 112.15 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.8 m -59.49 144.69 46.47 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -67.6 121.66 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.538 -0.726 . . . . 0.0 109.588 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.286 . . 67.62 18.84 9.9 Favored 'General case' 0 CA--C 1.576 1.981 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 -160.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.8 57.35 2.21 Favored Glycine 0 N--CA 1.49 2.257 0 O-C-N 119.998 -1.689 . . . . 0.0 116.547 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.8 t -133.72 121.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 169.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.62 109.53 16.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.777 . . . . 0.0 109.097 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 -46.55 0.7 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 -161.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -104.65 138.18 41.36 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 118.283 1.042 . . . . 0.0 111.738 176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -83.09 92.87 7.49 Favored 'General case' 0 CA--C 1.568 1.645 0 O-C-N 121.534 -0.729 . . . . 0.0 111.196 172.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -72.7 152.08 41.87 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.0 p -69.6 149.49 48.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -53.68 -45.67 98.63 Favored Pre-proline 0 CA--C 1.578 2.03 0 CA-C-O 116.006 -1.95 . . . . 0.0 115.944 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.22 -31.4 74.49 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.773 2.74 . . . . 0.0 118.796 169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.0 tpp -65.93 -43.28 88.54 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 164.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -64.72 -46.93 80.18 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.28 19.24 0.97 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 117.824 2.527 . . . . 0.0 117.824 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.87 -58.27 3.39 Favored 'General case' 0 CA--C 1.569 1.695 0 CA-C-N 120.3 1.409 . . . . 0.0 114.056 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.84 89.12 0.94 Allowed Glycine 0 N--CA 1.488 2.142 0 CA-C-N 118.868 0.758 . . . . 0.0 114.747 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.81 -176.08 45.04 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-O 122.401 1.0 . . . . 0.0 115.463 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -130.77 151.08 51.6 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.961 0.886 . . . . 0.0 110.525 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -82.56 76.54 9.41 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.726 1.25 . . . . 0.0 113.517 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.2 p -72.98 159.37 85.47 Favored Pre-proline 0 CA--C 1.576 1.963 0 C-N-CA 124.355 1.062 . . . . 0.0 113.208 171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -49.69 -47.92 21.17 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.906 2.404 . . . . 0.0 117.705 171.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -52.44 -51.45 59.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 165.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.0 91.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.2 -48.99 77.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.277 3.1 pp0? -63.98 -35.98 82.46 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 174.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.78 -53.34 58.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -59.1 -41.67 88.65 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.89 -10.2 59.42 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -73.83 -57.26 4.1 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 120.657 1.571 . . . . 0.0 111.869 162.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -141.77 105.23 5.81 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 119.545 1.066 . . . . 0.0 108.763 169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.5 -34.67 9.12 Favored 'Trans proline' 0 CA--C 1.562 1.88 0 N-CA-C 117.239 1.977 . . . . 0.0 117.239 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -36.39 84.17 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.12 -43.54 82.16 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 168.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 87.9 t -72.13 -53.95 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.473 1.033 . . . . 0.0 113.061 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.45 99.71 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -74.36 96.78 2.91 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-O 122.913 1.34 . . . . 0.0 113.573 -172.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.31 34.25 5.66 Favored Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -166.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.6 t -71.61 143.13 49.91 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.723 1.261 . . . . 0.0 112.949 164.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -76.6 6.12 6.39 Favored 'General case' 0 CA--C 1.579 2.062 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 168.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -74.79 108.65 7.68 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 120.583 -1.323 . . . . 0.0 112.225 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.68 77.38 7.52 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 122.659 1.219 . . . . 0.0 112.707 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -143.98 129.53 19.07 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -62.23 1.73 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 170.56 155.92 10.85 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 116.039 1.176 . . . . 0.0 116.039 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -101.01 98.61 8.87 Favored Pre-proline 0 CA--C 1.575 1.911 0 CA-C-O 118.07 -0.967 . . . . 0.0 108.53 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.35 -37.3 7.93 Favored 'Trans proline' 0 CA--C 1.564 2.002 0 N-CA-C 118.029 2.281 . . . . 0.0 118.029 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.26 122.89 27.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 119.369 0.986 . . . . 0.0 110.661 172.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.62 -33.54 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.54 -47.12 63.5 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -61.04 -41.18 96.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -59.23 -55.69 31.71 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 170.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.03 79.3 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -56.75 -51.87 67.2 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 120.715 1.598 . . . . 0.0 114.482 163.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.8 -44.11 90.7 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.03 -31.12 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 CA-C-N 119.756 1.162 . . . . 0.0 114.001 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.39 93.25 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 121.302 1.864 . . . . 0.0 115.779 158.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.68 -45.89 90.73 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.14 -33.5 73.51 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 169.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.38 -36.75 85.16 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 164.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -43.91 98.41 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.541 1.776 . . . . 0.0 117.541 160.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -87.01 55.62 3.65 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 118.191 0.996 . . . . 0.0 113.134 171.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.655 -172.775 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.667 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 CA--C 1.565 1.522 0 CA-C-O 122.041 0.924 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.95 78.42 1.79 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -107.69 110.26 62.59 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.931 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.4 -24.36 14.26 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 N-CA-C 118.49 2.458 . . . . 0.0 118.49 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.39 -48.68 76.86 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 167.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.81 -41.96 74.95 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 158.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.22 -35.91 61.15 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 119.608 2.603 . . . . 0.0 119.608 170.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.27 -45.3 88.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -56.61 -47.38 79.76 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.03 -44.29 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 169.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -59.73 -11.85 5.94 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 169.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.92 -35.95 19.01 Favored Glycine 0 CA--C 1.557 2.692 0 N-CA-C 119.037 2.375 . . . . 0.0 119.037 157.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.73 -28.85 70.24 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 162.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -94.61 -39.3 10.43 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -27.48 53.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 119.899 3.296 . . . . 0.0 119.899 -173.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.46 75.94 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.8 m -95.98 -40.17 9.4 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -111.94 136.77 50.83 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.637 1.175 . . . . 0.0 111.634 -168.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -111.81 121.27 44.6 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.027 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -79.46 -12.79 59.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -85.9 54.81 3.26 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 121.628 2.013 . . . . 0.0 112.856 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.6 37.93 34.7 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 120.251 2.86 . . . . 0.0 120.251 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -131.83 145.96 51.86 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.37 1.085 . . . . 0.0 112.067 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -110.56 113.57 26.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 -176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.2 -107.7 3.06 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 122.044 -0.41 . . . . 0.0 113.392 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.65 -54.69 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-N 117.174 0.487 . . . . 0.0 110.574 170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.47 167.96 30.4 Favored Glycine 0 CA--C 1.562 3.028 0 CA-C-N 118.817 0.735 . . . . 0.0 114.758 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.78 175.51 7.18 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.687 2.258 . . . . 0.0 115.958 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -68.61 113.4 6.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 111.746 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.32 -3.82 53.76 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -70.46 113.95 8.09 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 119.932 1.242 . . . . 0.0 112.227 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.03 40.24 30.54 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -167.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -87.12 -29.03 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 171.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.93 111.2 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 120.369 1.441 . . . . 0.0 109.782 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.32 68.83 Favored Glycine 0 CA--C 1.555 2.58 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 -163.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -78.99 144.4 34.76 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.273 2.036 . . . . 0.0 112.997 -173.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -56.34 138.11 51.42 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.41 125.49 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 123.669 0.787 . . . . 0.0 109.997 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.275 . . 64.11 18.43 11.24 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 118.132 2.642 . . . . 0.0 118.132 -161.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.31 55.29 3.56 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 120.208 -1.557 . . . . 0.0 116.477 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 92.4 t -132.49 101.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 166.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.68 102.18 4.52 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.481 0.658 . . . . 0.0 110.301 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.05 -51.82 0.6 Allowed Glycine 0 N--CA 1.487 2.036 0 CA-C-O 119.326 -0.708 . . . . 0.0 113.974 -157.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -87.33 131.21 34.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.299 1.05 . . . . 0.0 111.03 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.05 89.86 6.96 Favored 'General case' 0 CA--C 1.567 1.612 0 O-C-N 121.592 -0.692 . . . . 0.0 111.74 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -73.11 153.94 40.58 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 p -67.37 147.05 53.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -52.02 -43.04 88.56 Favored Pre-proline 0 CA--C 1.575 1.926 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.24 -35.89 98.95 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 CA-C-N 124.62 2.686 . . . . 0.0 118.873 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 tpp -62.89 -44.06 97.11 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 166.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -65.73 -46.49 78.73 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.35 -23.14 63.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -62.64 -64.53 0.89 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.79 -162.71 54.4 Favored Glycine 0 CA--C 1.551 2.302 0 N-CA-C 116.174 1.23 . . . . 0.0 116.174 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.09 -165.3 43.22 Favored Glycine 0 CA--C 1.55 2.236 0 O-C-N 121.93 -0.747 . . . . 0.0 114.825 -169.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.38 154.38 45.06 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.464 1.126 . . . . 0.0 111.481 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -81.72 76.02 8.64 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.644 1.211 . . . . 0.0 113.061 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.8 p -67.82 156.96 88.05 Favored Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 123.821 0.849 . . . . 0.0 113.101 172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -50.51 -46.72 27.99 Favored 'Trans proline' 0 CA--C 1.565 2.063 0 C-N-CA 122.675 2.25 . . . . 0.0 117.278 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.253 13.1 pt-20 -49.56 -53.67 22.4 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 163.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.79 98.26 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 mt -59.29 -49.23 78.63 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -63.29 -33.92 76.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -59.73 -55.68 31.32 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.639 1.109 . . . . 0.0 113.975 162.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.9 mt -71.66 -16.99 62.28 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.5 m -66.88 -54.61 20.51 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 120.725 1.602 . . . . 0.0 112.64 164.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -146.79 106.52 3.98 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.778 1.172 . . . . 0.0 108.939 167.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -73.08 -31.08 10.07 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 N-CA-C 117.573 2.105 . . . . 0.0 117.573 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -67.61 -38.06 83.4 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.04 96.75 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.19 -55.78 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.32 0.963 . . . . 0.0 112.408 172.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.1 t -109.29 99.38 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.28 102.72 5.97 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.6 0.714 . . . . 0.0 111.816 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.55 42.02 4.95 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 116.948 1.539 . . . . 0.0 116.948 -163.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -81.77 141.39 33.56 Favored 'General case' 0 CA--C 1.565 1.539 0 O-C-N 121.684 -0.892 . . . . 0.0 111.451 160.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -69.86 1.72 4.13 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 165.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -76.31 104.88 7.05 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.238 1.381 . . . . 0.0 111.965 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.47 75.1 10.29 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 122.775 1.274 . . . . 0.0 112.167 172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.29 134.82 40.3 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.587 1.155 . . . . 0.0 108.046 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.98 2.55 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 168.6 147.83 5.52 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 115.586 0.995 . . . . 0.0 115.586 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.2 mt -95.67 100.84 6.78 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.478 163.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.02 -35.18 9.33 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.694 2.262 . . . . 0.0 117.721 -175.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -85.62 134.26 34.0 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 122.08 0.943 . . . . 0.0 111.961 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.48 -45.46 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -55.71 -44.1 77.13 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 173.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.31 -44.46 79.93 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 121.127 1.785 . . . . 0.0 115.245 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 85.3 mtm-85 -63.19 -52.61 61.63 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.49 90.07 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -52.8 -53.85 42.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 164.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.18 -43.45 98.86 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -65.78 -34.84 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 CA-C-N 119.839 1.2 . . . . 0.0 114.109 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.52 74.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 158.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -61.22 -46.02 92.14 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -53.66 -41.52 66.92 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.27 -38.35 90.73 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 168.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.13 12.82 29.29 Favored Glycine 0 CA--C 1.559 2.807 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 163.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -138.95 82.62 1.91 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.538 1.669 . . . . 0.0 106.884 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--O 1.257 1.479 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.487 -172.518 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.642 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.21 78.06 1.16 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -169.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -107.16 113.76 61.96 Favored Pre-proline 0 CA--C 1.576 1.972 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.183 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -72.28 -25.47 18.6 Favored 'Trans proline' 0 CA--C 1.565 2.041 0 N-CA-C 118.539 2.477 . . . . 0.0 118.539 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.67 -47.67 82.67 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 167.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.36 90.08 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 160.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.61 -36.34 47.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 119.734 2.654 . . . . 0.0 119.734 167.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -55.91 -50.23 71.26 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.271 64.5 pttt -64.76 -37.89 89.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.24 -40.53 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-N 120.583 1.538 . . . . 0.0 113.506 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -54.32 -17.48 3.02 Favored 'General case' 0 CA--C 1.579 2.087 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 163.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.4 -37.75 3.62 Favored Glycine 0 CA--C 1.556 2.61 0 N-CA-C 119.872 2.709 . . . . 0.0 119.872 159.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -66.55 -31.53 72.31 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 165.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -83.45 -40.1 19.72 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -55.08 -30.9 60.64 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -172.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.95 75.77 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 169.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.0 m -93.89 -39.53 10.64 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -113.52 130.27 56.38 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.591 1.157 . . . . 0.0 111.305 -168.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -101.92 125.35 48.58 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.605 0.717 . . . . 0.0 111.804 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -68.92 -32.98 73.0 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.38 55.08 1.83 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 120.677 1.58 . . . . 0.0 113.706 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.88 32.62 34.24 Favored Glycine 0 CA--C 1.557 2.667 0 N-CA-C 120.748 3.059 . . . . 0.0 120.748 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -118.93 144.18 46.58 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 118.911 1.355 . . . . 0.0 112.158 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -124.44 109.57 13.44 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.93 -94.39 0.71 Allowed Glycine 0 N--CA 1.492 2.368 0 O-C-N 121.901 -0.499 . . . . 0.0 113.891 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.45 -56.69 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.872 -0.585 . . . . 0.0 110.598 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.81 167.71 15.48 Favored Glycine 0 CA--C 1.564 3.13 0 CA-C-N 119.194 0.906 . . . . 0.0 114.704 158.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.33 175.94 7.89 Favored 'Trans proline' 0 CA--C 1.566 2.117 0 C-N-CA 122.683 2.255 . . . . 0.0 116.242 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -74.26 109.56 7.85 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 120.393 -1.442 . . . . 0.0 113.044 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 99.2 mt -73.83 -6.61 48.12 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -66.38 120.94 14.19 Favored 'General case' 0 CA--C 1.569 1.707 0 O-C-N 121.19 -0.944 . . . . 0.0 111.165 162.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.14 30.54 54.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 118.278 2.071 . . . . 0.0 118.278 -171.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -85.66 -32.06 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -72.26 114.77 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.732 1.605 . . . . 0.0 110.253 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.55 -7.81 81.13 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -164.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -82.62 146.43 29.13 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 120.38 2.09 . . . . 0.0 112.004 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.7 m -60.73 146.65 45.12 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.4 121.56 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.479 -0.763 . . . . 0.0 109.374 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.289 . . 66.59 21.81 10.63 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 118.34 2.718 . . . . 0.0 118.34 -159.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 56.51 1.9 Allowed Glycine 0 N--CA 1.488 2.14 0 O-C-N 120.0 -1.687 . . . . 0.0 116.343 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.59 119.83 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 165.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.8 106.61 14.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.81 . . . . 0.0 109.008 163.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.4 -51.03 0.56 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.565 -0.575 . . . . 0.0 114.214 -159.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -94.15 136.6 34.27 Favored 'General case' 0 CA--C 1.568 1.655 0 CA-C-N 117.993 0.896 . . . . 0.0 111.629 172.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -82.43 99.25 9.32 Favored 'General case' 0 CA--C 1.566 1.594 0 O-C-N 121.69 -0.632 . . . . 0.0 110.996 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.65 155.6 27.99 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.7 p -70.15 148.43 48.7 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -54.75 -44.98 99.71 Favored Pre-proline 0 CA--C 1.577 2.015 0 CA-C-O 115.815 -2.04 . . . . 0.0 116.054 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -62.06 -31.15 83.58 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 CA-C-N 124.844 2.766 . . . . 0.0 118.927 168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.4 tpp -66.01 -43.7 86.92 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 163.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -63.95 -46.7 83.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 172.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 18.14 0.99 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -75.53 -59.83 2.58 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 120.429 1.468 . . . . 0.0 114.079 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.87 91.1 1.06 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-N 118.992 0.815 . . . . 0.0 114.744 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.8 -175.92 44.41 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 122.354 0.974 . . . . 0.0 115.371 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -131.46 150.51 52.12 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.724 0.774 . . . . 0.0 110.513 173.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.88 76.16 8.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.902 1.334 . . . . 0.0 113.583 -170.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.2 p -74.06 160.22 82.19 Favored Pre-proline 0 CA--C 1.576 1.979 0 C-N-CA 124.552 1.141 . . . . 0.0 113.225 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -50.52 -44.33 40.44 Favored 'Trans proline' 0 CA--C 1.564 1.993 0 N-CA-C 118.042 2.285 . . . . 0.0 118.042 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.26 13.8 pt-20 -55.01 -54.36 43.93 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 164.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.47 -43.78 96.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.87 -49.71 76.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -64.47 -35.1 79.83 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -59.73 -54.24 48.58 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 164.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -60.77 -42.75 98.12 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.45 -14.72 61.75 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.929 1.825 . . . . 0.0 115.929 171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -69.62 -56.86 6.12 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 162.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -142.95 106.37 5.3 Favored Pre-proline 0 CA--C 1.574 1.88 0 CA-C-N 119.684 1.129 . . . . 0.0 109.008 169.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -72.19 -34.33 8.19 Favored 'Trans proline' 0 CA--C 1.562 1.916 0 N-CA-C 117.319 2.007 . . . . 0.0 117.319 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.88 -35.88 82.56 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 170.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.3 -42.59 92.9 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.6 t -75.18 -55.37 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 119.335 0.97 . . . . 0.0 112.807 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 98.76 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -73.91 96.1 2.56 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.026 1.394 . . . . 0.0 113.574 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.71 32.38 5.7 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 -166.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.1 t -72.38 139.97 48.15 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.097 1.448 . . . . 0.0 113.0 167.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -78.38 11.68 2.31 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.421 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -76.16 108.35 9.02 Favored 'General case' 0 CA--C 1.562 1.409 0 O-C-N 120.582 -1.324 . . . . 0.0 111.497 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.33 77.05 7.11 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 122.679 1.228 . . . . 0.0 112.628 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -140.05 129.87 24.6 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.264 1.026 . . . . 0.0 108.279 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.11 -61.56 1.94 Allowed 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 169.64 154.26 9.1 Favored Glycine 0 CA--C 1.544 1.883 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.58 99.69 9.23 Favored Pre-proline 0 CA--C 1.574 1.878 0 CA-C-O 117.97 -1.014 . . . . 0.0 108.28 164.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.58 -34.13 12.36 Favored 'Trans proline' 0 CA--C 1.566 2.078 0 C-N-CA 122.624 2.216 . . . . 0.0 117.747 -175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -78.49 130.23 35.79 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 119.206 0.912 . . . . 0.0 112.206 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.37 -42.92 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 165.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -52.14 45.23 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.7 -44.15 85.67 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -62.1 -54.96 33.85 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.58 91.03 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -59.91 -50.01 75.46 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.015 1.28 . . . . 0.0 114.426 168.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.72 -47.6 84.01 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 66.8 mt -60.29 -40.86 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 CA-C-N 120.025 1.284 . . . . 0.0 114.144 173.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.65 -44.16 65.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 162.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -63.48 -43.45 97.27 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 168.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.8 mt -57.07 -41.25 78.43 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 167.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.69 -42.19 83.17 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 166.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.74 9.95 41.4 Favored Glycine 0 CA--C 1.558 2.765 0 N-CA-C 120.01 2.764 . . . . 0.0 120.01 165.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -127.26 79.64 1.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.704 1.752 . . . . 0.0 106.606 169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.158 -160.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.64 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.67 71.82 0.8 Allowed 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 121.946 0.879 . . . . 0.0 112.401 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -107.95 109.04 61.99 Favored Pre-proline 0 CA--C 1.573 1.855 0 CA-C-O 117.446 -1.264 . . . . 0.0 110.961 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.52 -27.08 39.71 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 N-CA-C 119.023 2.663 . . . . 0.0 119.023 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.17 -50.67 72.22 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.18 -39.31 75.06 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 161.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -52.87 -39.16 55.66 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 119.541 2.576 . . . . 0.0 119.541 165.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.1 -43.18 86.97 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 63.9 pttt -68.59 -38.94 81.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.82 -41.06 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.309 1.413 . . . . 0.0 113.349 165.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.83 -17.2 14.65 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 166.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.01 -37.91 4.46 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 119.355 2.502 . . . . 0.0 119.355 157.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -67.52 -29.36 68.75 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 165.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 m -83.51 -41.01 18.46 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -55.66 -29.93 60.13 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 119.731 3.234 . . . . 0.0 119.731 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.1 82.67 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 167.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.2 m -90.71 -42.88 10.47 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -111.8 129.8 56.02 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.386 1.075 . . . . 0.0 111.342 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -103.33 134.1 47.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.767 -0.583 . . . . 0.0 111.754 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -81.19 -16.01 54.07 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 172.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -94.12 52.8 1.66 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.64 1.564 . . . . 0.0 112.842 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.37 56.93 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 121.16 3.224 . . . . 0.0 121.16 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -113.64 110.21 19.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 119.028 1.414 . . . . 0.0 110.922 -176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -85.48 119.59 26.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.153 -0.967 . . . . 0.0 112.07 170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.87 -95.66 0.59 Allowed Glycine 0 N--CA 1.491 2.319 0 O-C-N 123.348 0.405 . . . . 0.0 113.384 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' O ' HMD3 ' A' ' 101' ' ' HEC . 50.2 t -75.24 -54.15 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.618 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.21 162.0 14.61 Favored Glycine 0 CA--C 1.563 3.049 0 CA-C-N 119.363 0.983 . . . . 0.0 114.989 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -75.27 127.5 10.55 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 123.03 2.487 . . . . 0.0 113.697 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -36.6 125.05 0.84 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 118.748 2.869 . . . . 0.0 118.748 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -86.48 2.86 46.37 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 117.555 2.428 . . . . 0.0 117.555 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -68.66 115.1 7.64 Favored 'General case' 0 CA--C 1.566 1.564 0 O-C-N 120.961 -1.087 . . . . 0.0 111.63 163.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.97 38.9 21.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 p -90.7 -32.47 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -73.26 116.15 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 120.956 1.707 . . . . 0.0 109.778 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 -2.18 86.49 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 118.934 2.334 . . . . 0.0 118.934 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -75.05 139.01 42.54 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 120.035 1.917 . . . . 0.0 111.942 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.3 m -56.96 143.81 36.41 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.8 t -70.5 123.1 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 O-C-N 121.574 -0.704 . . . . 0.0 109.243 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.319 . . 67.82 32.11 5.46 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -158.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.02 53.98 0.78 Allowed Glycine 0 N--CA 1.488 2.122 0 O-C-N 120.351 -1.468 . . . . 0.0 116.106 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -134.73 106.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.01 103.23 4.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.613 -0.679 . . . . 0.0 110.363 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.59 -49.27 0.69 Allowed Glycine 0 N--CA 1.488 2.14 0 CA-C-O 119.489 -0.617 . . . . 0.0 114.556 -158.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -87.04 138.71 31.26 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-N 118.317 1.059 . . . . 0.0 112.802 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -81.25 92.41 6.34 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 121.489 0.661 . . . . 0.0 111.742 173.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.95 150.98 35.89 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.8 t -64.65 149.4 49.05 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 113.333 167.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.59 -45.41 99.66 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.53 -27.7 85.32 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 124.637 2.692 . . . . 0.0 118.98 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.3 tpp -67.56 -44.81 77.34 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 163.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -63.28 -46.52 86.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 172.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.14 25.89 0.8 Allowed 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.355 2.354 . . . . 0.0 117.355 170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -78.71 -59.89 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.48 -1.388 . . . . 0.0 113.976 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 89.39 0.97 Allowed Glycine 0 N--CA 1.487 2.039 0 CA-C-N 118.806 0.73 . . . . 0.0 114.534 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.0 -178.38 44.24 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.368 0.982 . . . . 0.0 115.478 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -132.81 150.63 52.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 110.443 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -82.95 77.64 9.65 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.974 1.368 . . . . 0.0 113.477 -170.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.1 p -77.81 159.8 75.63 Favored Pre-proline 0 CA--C 1.576 1.948 0 C-N-CA 124.478 1.111 . . . . 0.0 112.778 172.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -49.94 -47.33 23.95 Favored 'Trans proline' 0 CA--C 1.565 2.074 0 C-N-CA 122.95 2.433 . . . . 0.0 118.005 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.07 -44.63 71.31 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 166.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.31 -46.38 70.4 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.35 -48.31 77.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 171.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.27 2.6 pp0? -64.41 -36.31 83.74 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.45 -53.13 60.55 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 165.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -58.27 -43.63 88.04 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.41 -13.02 61.35 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 170.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.8 m -68.01 -57.39 6.24 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.791 1.632 . . . . 0.0 112.164 162.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -144.83 105.27 4.53 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-N 119.382 0.992 . . . . 0.0 108.714 169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.83 -32.95 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 N-CA-C 117.234 1.974 . . . . 0.0 117.234 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -32.25 73.55 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 170.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 -46.33 67.18 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 167.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.7 t -70.89 -48.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 119.393 0.997 . . . . 0.0 113.64 176.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.67 99.35 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -76.83 99.58 5.21 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.554 0.693 . . . . 0.0 112.498 -172.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.23 36.66 5.62 Favored Glycine 0 CA--C 1.555 2.593 0 N-CA-C 117.389 1.716 . . . . 0.0 117.389 -164.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -70.01 144.66 52.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.828 -0.807 . . . . 0.0 112.924 165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.2 4.57 12.3 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 116.879 2.178 . . . . 0.0 116.879 164.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.416 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -77.29 108.21 10.26 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 120.423 1.465 . . . . 0.0 111.94 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.3 77.7 8.15 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 122.565 1.174 . . . . 0.0 112.533 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -142.97 127.99 18.48 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.51 -57.96 3.6 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.4 152.58 7.04 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.16 99.49 8.24 Favored Pre-proline 0 CA--C 1.574 1.889 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.49 -31.7 16.81 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 N-CA-C 118.362 2.408 . . . . 0.0 118.362 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.86 127.2 34.52 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 119.5 1.046 . . . . 0.0 111.594 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.0 -45.97 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -58.73 -38.69 78.94 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 172.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.048 1.749 . . . . 0.0 114.743 168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.55 -54.15 48.92 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 166.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.6 -38.37 81.06 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -57.61 -52.29 66.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.299 1.409 . . . . 0.0 114.28 166.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.32 -45.64 87.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.261 73.9 mt -65.92 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.841 0 CA-C-N 119.866 1.212 . . . . 0.0 113.464 176.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.14 64.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 159.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -63.08 -45.48 91.92 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.75 -37.94 74.5 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 166.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.53 -40.03 90.0 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 166.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.79 -38.4 96.44 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 161.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -90.13 56.81 3.54 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-N 118.56 1.18 . . . . 0.0 113.479 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.615 173.562 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.612 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 CA--C 1.561 1.383 0 CA-C-O 121.461 0.648 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.29 . . 62.11 36.76 15.02 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -101.5 111.81 64.3 Favored Pre-proline 0 CA--C 1.576 1.962 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -69.63 -27.53 26.99 Favored 'Trans proline' 0 CA--C 1.565 2.04 0 N-CA-C 118.584 2.494 . . . . 0.0 118.584 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.79 83.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 166.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.71 84.19 Favored 'General case' 0 CA--C 1.569 1.708 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 162.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.94 -36.32 60.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 165.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.42 92.5 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 169.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.26 64.8 pttt -68.29 -37.41 80.63 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 168.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.55 -38.7 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 CA-C-N 120.333 1.424 . . . . 0.0 113.697 165.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.2 -16.11 7.37 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 166.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -44.97 -37.81 5.65 Favored Glycine 0 CA--C 1.557 2.672 0 N-CA-C 119.551 2.581 . . . . 0.0 119.551 158.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.75 -30.75 71.05 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 m -87.83 -35.49 17.77 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -55.78 -32.1 63.17 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.43 -34.49 69.0 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 170.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.8 m -100.24 -38.5 8.46 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -111.46 129.23 56.1 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.484 1.114 . . . . 0.0 110.813 -169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -90.92 -25.14 19.95 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 -161.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt 64.73 -31.19 0.13 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -168.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -79.42 50.68 1.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.421 -1.424 . . . . 0.0 114.568 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.85 21.27 0.85 Allowed Glycine 0 CA--C 1.56 2.9 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -142.76 145.04 32.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.471 1.109 . . . . 0.0 110.061 -171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.98 166.06 14.16 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -152.57 -98.92 0.17 Allowed Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.535 -0.728 . . . . 0.0 112.568 170.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.67 -51.81 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.346 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.42 177.29 22.89 Favored Glycine 0 CA--C 1.564 3.096 0 CA-C-N 119.238 0.926 . . . . 0.0 115.22 159.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.79 172.82 11.03 Favored 'Trans proline' 0 CA--C 1.566 2.11 0 C-N-CA 122.923 2.415 . . . . 0.0 115.573 171.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -74.62 113.88 12.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.242 -1.536 . . . . 0.0 112.542 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.64 2.04 12.93 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -72.48 117.37 14.07 Favored 'General case' 0 CA--C 1.565 1.533 0 O-C-N 121.045 -1.035 . . . . 0.0 110.407 167.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.99 32.74 43.5 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.799 1.879 . . . . 0.0 117.799 -171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -84.01 -32.6 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.4 113.64 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-N 120.589 1.54 . . . . 0.0 109.859 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.42 -10.27 73.24 Favored Glycine 0 CA--C 1.554 2.51 0 N-CA-C 118.83 2.292 . . . . 0.0 118.83 -163.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -87.16 149.04 24.92 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 120.375 2.088 . . . . 0.0 112.139 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.9 m -57.85 146.76 30.67 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.15 122.76 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.705 -0.622 . . . . 0.0 109.347 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.77 25.48 6.3 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -158.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.15 51.11 3.11 Favored Glycine 0 N--CA 1.489 2.173 0 O-C-N 119.901 -1.749 . . . . 0.0 116.875 -173.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -131.27 106.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 162.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.39 99.15 4.75 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.482 -0.761 . . . . 0.0 109.348 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.75 -31.9 1.74 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 116.845 1.498 . . . . 0.0 116.845 -157.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -104.79 140.86 37.48 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.845 1.822 . . . . 0.0 110.988 170.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -82.2 94.62 7.32 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.652 -0.655 . . . . 0.0 111.695 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -77.32 159.9 29.22 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.7 p -72.01 145.48 48.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.029 -1.044 . . . . 0.0 112.839 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -51.81 -43.05 87.55 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -59.03 -31.66 96.07 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 N-CA-C 119.208 2.734 . . . . 0.0 119.208 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 34.5 tpp -68.17 -43.36 78.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 164.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -64.68 -46.59 81.75 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.673 1.361 . . . . 0.0 114.673 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.62 28.57 0.86 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -77.49 -59.16 2.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.47 -1.394 . . . . 0.0 113.816 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.86 87.18 1.15 Allowed Glycine 0 N--CA 1.487 2.079 0 CA-C-N 118.704 0.684 . . . . 0.0 114.525 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.08 -178.55 43.44 Favored Glycine 0 CA--C 1.544 1.878 0 CA-C-O 122.588 1.104 . . . . 0.0 115.624 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -130.59 151.12 51.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.543 0.737 . . . . 0.0 110.328 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -81.94 75.86 8.86 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.7 1.238 . . . . 0.0 113.632 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.9 p -72.88 161.12 80.94 Favored Pre-proline 0 CA--C 1.576 1.943 0 C-N-CA 124.343 1.057 . . . . 0.0 113.279 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.04 -49.18 15.91 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.823 2.348 . . . . 0.0 117.505 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -53.07 -48.28 67.84 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.0 -46.65 77.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.75 -47.07 87.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -61.61 -35.35 77.63 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.22 -53.04 50.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.99 -42.74 90.74 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.21 -13.37 60.44 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 172.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.9 m -71.12 -54.42 11.13 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 120.444 1.474 . . . . 0.0 112.425 160.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -142.66 106.25 5.43 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-N 120.025 1.284 . . . . 0.0 109.121 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.72 -32.6 9.2 Favored 'Trans proline' 0 CA--C 1.56 1.822 0 N-CA-C 117.397 2.037 . . . . 0.0 117.397 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -66.29 -32.55 74.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 170.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.07 -45.46 81.22 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.14 -49.36 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-N 119.412 1.006 . . . . 0.0 113.243 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -109.59 99.25 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.07 101.91 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.665 0.745 . . . . 0.0 112.116 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.0 42.64 4.95 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -163.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -78.5 136.85 37.68 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 121.715 -0.873 . . . . 0.0 111.694 162.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -71.11 4.97 2.34 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.5 ttt -74.92 106.97 6.69 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 119.988 1.267 . . . . 0.0 111.716 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.64 77.05 9.92 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 122.635 1.207 . . . . 0.0 112.284 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -139.58 133.77 31.21 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 124.305 1.042 . . . . 0.0 108.271 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.34 -62.81 1.56 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 171.17 147.37 5.61 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.98 103.67 14.16 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 117.801 -1.095 . . . . 0.0 109.045 166.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.81 -30.06 14.74 Favored 'Trans proline' 0 CA--C 1.566 2.114 0 N-CA-C 118.168 2.334 . . . . 0.0 118.168 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -84.36 121.49 27.61 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 119.485 1.039 . . . . 0.0 111.406 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 tp -51.62 -45.75 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -51.04 -46.72 61.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.37 -39.33 81.84 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -57.72 -54.37 47.64 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 164.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.22 91.85 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -54.99 -49.65 70.95 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD21 HMB1 ' A' ' 101' ' ' HEC . 28.3 tp -57.62 -45.76 84.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 169.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.18 -43.17 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.011 0 CA-C-N 119.69 1.132 . . . . 0.0 113.418 173.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.34 -43.85 71.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.888 2.181 . . . . 0.0 116.888 163.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -60.04 -48.51 81.41 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.51 -30.63 69.84 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 171.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.4 -48.62 74.72 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 161.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.39 95.95 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 118.657 2.223 . . . . 0.0 118.657 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -80.73 76.84 7.61 Favored 'General case' 0 CA--C 1.565 1.55 0 CA-C-O 122.41 1.1 . . . . 0.0 109.936 167.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.794 -175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.651 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 121.056 0.455 . . . . 0.0 111.599 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.6 101.38 3.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 0.0 111.495 -167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -102.26 117.56 60.92 Favored Pre-proline 0 CA--C 1.576 1.959 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.885 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.3 -24.14 20.01 Favored 'Trans proline' 0 CA--C 1.565 2.07 0 N-CA-C 118.707 2.541 . . . . 0.0 118.707 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.17 -47.33 80.25 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 166.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.84 -41.53 82.54 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 160.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.7 -40.79 64.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 167.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -42.79 78.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 166.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.01 -46.22 88.64 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 -41.89 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -56.32 -17.91 9.18 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.05 -37.89 5.84 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 119.318 2.487 . . . . 0.0 119.318 157.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -69.85 -23.56 63.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 166.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -90.75 -39.35 12.45 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 175.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -55.55 -30.16 60.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.693 3.22 . . . . 0.0 119.693 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.84 -36.7 74.99 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.0 m -94.38 -39.55 10.4 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -111.86 130.22 55.89 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.451 1.1 . . . . 0.0 111.476 -168.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -90.57 141.94 28.26 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.853 0.835 . . . . 0.0 112.694 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -84.83 -21.45 29.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 164.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -79.89 52.6 1.51 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 121.7 2.046 . . . . 0.0 114.613 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 49.52 21.8 3.42 Favored Glycine 0 CA--C 1.557 2.668 0 N-CA-C 122.523 3.769 . . . . 0.0 122.523 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -140.85 130.77 24.5 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 119.035 1.417 . . . . 0.0 109.634 -172.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.88 160.77 29.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -151.27 -103.31 0.25 Allowed Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.465 -0.772 . . . . 0.0 113.188 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.28 -51.22 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.331 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.88 167.79 15.46 Favored Glycine 0 CA--C 1.565 3.199 0 N-CA-C 115.468 0.947 . . . . 0.0 115.468 160.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.45 139.12 31.04 Favored 'Trans proline' 0 CA--C 1.563 1.975 0 C-N-CA 123.353 2.702 . . . . 0.0 113.679 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -52.73 121.95 8.16 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.51 -2.54 50.17 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -71.36 121.71 19.02 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-N 119.931 1.241 . . . . 0.0 110.65 162.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.27 31.51 57.1 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 118.122 2.009 . . . . 0.0 118.122 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.8 -30.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.6 t -74.37 112.87 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 120.372 1.442 . . . . 0.0 109.779 -173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 -8.2 78.96 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 118.871 2.309 . . . . 0.0 118.871 -163.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -84.56 148.58 26.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 120.522 2.161 . . . . 0.0 111.969 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.0 m -60.04 143.77 51.14 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.0 t -71.74 117.49 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.288 . . 65.35 60.77 0.74 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -155.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.01 57.93 0.72 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.1 t -140.05 113.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 165.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.81 104.32 2.87 Favored 'General case' 0 CA--C 1.568 1.664 0 O-C-N 121.7 -0.625 . . . . 0.0 111.229 167.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 130.66 -17.71 5.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.042 1.977 . . . . 0.0 118.042 -161.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -111.36 137.34 49.26 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.493 2.147 . . . . 0.0 111.864 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.75 93.85 6.89 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 121.432 0.634 . . . . 0.0 111.61 172.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -78.91 149.33 32.42 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 62.1 m -67.71 148.05 51.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 168.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.7 -43.0 99.17 Favored Pre-proline 0 CA--C 1.574 1.882 0 CA-C-O 115.856 -2.021 . . . . 0.0 116.366 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.29 -29.54 90.56 Favored 'Trans proline' 0 CA--C 1.561 1.849 0 CA-C-N 124.746 2.731 . . . . 0.0 119.171 167.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 31.3 tpp -68.9 -43.84 74.41 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -63.77 -45.85 87.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.43 19.58 0.77 Allowed 'General case' 0 CA--C 1.576 1.948 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -78.9 -60.53 2.34 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.344 1.429 . . . . 0.0 113.466 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.59 91.12 0.95 Allowed Glycine 0 N--CA 1.487 2.054 0 CA-C-N 118.807 0.73 . . . . 0.0 114.578 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.28 -174.17 45.92 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-O 122.594 1.108 . . . . 0.0 115.585 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -132.42 152.27 51.55 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.644 0.735 . . . . 0.0 110.313 171.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -82.0 79.0 8.63 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.681 1.229 . . . . 0.0 113.507 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.9 p -76.33 158.77 81.19 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.283 1.033 . . . . 0.0 112.883 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -50.36 -47.78 22.89 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.978 2.452 . . . . 0.0 118.039 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -52.92 -52.02 59.24 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 165.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.24 -44.48 96.47 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.79 -48.82 78.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 168.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.29 2.8 pp0? -64.89 -35.14 80.18 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 174.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.0 -56.44 22.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.729 -1.232 . . . . 0.0 113.891 163.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.89 -43.98 81.87 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.98 -12.23 61.14 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 171.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.0 m -68.33 -55.94 10.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.712 1.596 . . . . 0.0 112.267 162.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -145.83 106.67 4.27 Favored Pre-proline 0 CA--C 1.575 1.923 0 CA-C-N 119.676 1.126 . . . . 0.0 109.027 167.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.71 -39.24 3.59 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 N-CA-C 117.212 1.966 . . . . 0.0 117.212 -175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.43 -19.71 62.96 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.34 -46.81 38.4 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 162.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.11 -51.48 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.647 1.112 . . . . 0.0 113.473 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -107.32 97.73 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -74.75 102.55 4.69 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 112.574 -170.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.92 6.74 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 117.739 1.855 . . . . 0.0 117.739 -165.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -77.09 143.59 39.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.609 1.204 . . . . 0.0 112.682 166.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.92 6.11 3.61 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.0 ttp -77.3 109.07 10.89 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 120.362 1.437 . . . . 0.0 112.23 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.01 77.94 7.87 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.505 1.145 . . . . 0.0 112.655 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -144.96 128.54 17.09 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.93 4.33 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.56 154.99 8.15 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 115.471 0.948 . . . . 0.0 115.471 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.5 mt -99.19 98.89 7.16 Favored Pre-proline 0 CA--C 1.575 1.912 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.177 164.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.88 -35.95 11.39 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.732 2.288 . . . . 0.0 117.849 -173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -74.72 130.86 40.24 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-N 119.012 0.824 . . . . 0.0 112.276 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -51.53 -43.22 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 165.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.42 -48.2 68.95 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.45 -42.23 77.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -65.72 -54.77 22.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.21 83.05 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.47 -47.89 82.56 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.28 -44.2 88.34 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 168.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -68.23 -31.54 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 CA-C-N 120.152 1.342 . . . . 0.0 114.235 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.53 -46.26 80.72 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 121.22 1.827 . . . . 0.0 115.924 156.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -61.58 -44.92 96.13 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.67 -40.57 79.66 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 169.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.55 -43.72 93.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 165.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.86 5.21 18.86 Favored Glycine 0 CA--C 1.559 2.8 0 N-CA-C 120.172 2.829 . . . . 0.0 120.172 163.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -126.31 79.75 1.87 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.474 1.637 . . . . 0.0 107.091 170.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 117.441 -1.266 . . . . 0.0 113.288 -171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.638 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.55 81.04 1.41 Allowed 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -168.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.02 109.99 56.94 Favored Pre-proline 0 CA--C 1.577 1.997 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.054 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.9 -34.65 99.18 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 N-CA-C 119.613 2.889 . . . . 0.0 119.613 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.63 -46.98 80.27 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.16 81.27 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 161.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.41 -38.8 81.36 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 119.004 2.361 . . . . 0.0 119.004 167.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -55.76 -48.18 75.73 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.101 1.451 . . . . 0.0 114.887 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -57.65 -46.17 84.56 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.63 -39.4 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -58.66 -15.32 11.22 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 168.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.44 -41.12 5.12 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.919 2.328 . . . . 0.0 118.919 155.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -69.73 -18.21 63.5 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' SG ' HMB1 ' A' ' 101' ' ' HEC . 5.4 m -98.24 -40.14 8.5 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -57.07 -24.4 53.67 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 119.744 3.238 . . . . 0.0 119.744 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.42 -34.48 64.45 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 164.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.4 m -106.72 -39.2 5.89 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -108.83 128.07 54.58 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.579 1.151 . . . . 0.0 111.154 -169.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -106.46 120.61 42.37 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.559 0.695 . . . . 0.0 111.586 -174.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.16 -16.86 61.98 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.04 51.07 1.1 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.78 2.082 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.13 34.88 6.23 Favored Glycine 0 CA--C 1.56 2.874 0 N-CA-C 120.063 2.785 . . . . 0.0 120.063 -167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -117.1 138.84 51.37 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 118.244 1.022 . . . . 0.0 112.222 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.35 111.47 21.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.09 -103.99 2.0 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 121.915 -0.49 . . . . 0.0 113.27 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -74.03 -53.75 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-O 118.861 -0.59 . . . . 0.0 110.812 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.49 168.04 21.56 Favored Glycine 0 CA--C 1.561 2.949 0 CA-C-N 119.045 0.839 . . . . 0.0 114.726 158.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.36 177.13 5.6 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.708 2.272 . . . . 0.0 115.86 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -73.45 108.89 6.57 Favored 'General case' 0 CA--C 1.564 1.492 0 O-C-N 120.716 -1.24 . . . . 0.0 112.163 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.8 -3.92 24.91 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 117.186 2.291 . . . . 0.0 117.186 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -69.63 115.34 8.77 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-N 119.323 0.965 . . . . 0.0 111.032 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.0 33.38 36.82 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 -170.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.4 p -82.62 -28.13 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.7 t -79.89 111.49 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.586 1.539 . . . . 0.0 109.582 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.47 -6.11 80.47 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.77 2.268 . . . . 0.0 118.77 -161.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.13 146.23 27.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 120.504 2.152 . . . . 0.0 111.929 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.5 m -58.84 147.3 34.14 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.55 121.96 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.54 -0.725 . . . . 0.0 109.472 175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.285 . . 66.62 22.99 10.39 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -158.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.89 52.73 3.61 Favored Glycine 0 N--CA 1.488 2.148 0 O-C-N 119.924 -1.735 . . . . 0.0 116.832 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.3 t -135.09 109.1 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 163.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -77.37 105.04 8.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.562 -0.711 . . . . 0.0 109.684 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.96 -51.13 0.6 Allowed Glycine 0 N--CA 1.489 2.188 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.312 -159.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -86.66 136.62 32.96 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-N 118.214 1.007 . . . . 0.0 111.514 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.76 95.48 6.0 Favored 'General case' 0 CA--C 1.568 1.652 0 O-C-N 121.633 -0.667 . . . . 0.0 111.565 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -79.65 157.45 27.25 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 t -73.21 149.4 42.89 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.787 0.803 . . . . 0.0 113.07 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.12 -45.89 99.77 Favored Pre-proline 0 CA--C 1.577 1.993 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -61.62 -29.27 83.83 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 CA-C-N 124.558 2.664 . . . . 0.0 118.926 167.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 32.5 tpp -67.1 -44.13 80.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 164.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.6 -46.56 85.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 172.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.78 28.05 0.81 Allowed 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.204 2.298 . . . . 0.0 117.204 170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -78.56 -59.25 2.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.405 -1.434 . . . . 0.0 113.782 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 87.81 1.18 Allowed Glycine 0 N--CA 1.487 2.089 0 CA-C-N 118.719 0.691 . . . . 0.0 114.358 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.58 -179.53 43.27 Favored Glycine 0 CA--C 1.544 1.868 0 CA-C-O 122.51 1.061 . . . . 0.0 115.481 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -131.64 150.39 52.17 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.669 0.747 . . . . 0.0 110.347 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -81.99 75.48 8.93 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.917 1.341 . . . . 0.0 113.655 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.0 p -73.71 160.53 81.87 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.536 1.135 . . . . 0.0 113.239 173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -50.03 -44.49 37.27 Favored 'Trans proline' 0 CA--C 1.565 2.061 0 N-CA-C 118.139 2.323 . . . . 0.0 118.139 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.25 13.2 pt-20 -54.38 -54.66 37.6 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.38 98.95 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.88 -49.09 77.89 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 169.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -64.27 -33.51 75.98 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.868 2.173 . . . . 0.0 116.868 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.98 -55.7 30.83 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 163.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -59.77 -41.08 90.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 173.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.63 -16.49 61.23 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -68.04 -55.35 12.87 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 120.457 1.48 . . . . 0.0 112.477 162.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -145.07 106.51 4.5 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-N 119.787 1.176 . . . . 0.0 109.015 169.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -72.86 -33.33 8.01 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 N-CA-C 117.182 1.955 . . . . 0.0 117.182 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -36.72 84.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.69 -35.17 74.86 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.21 -47.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-N 120.118 1.326 . . . . 0.0 113.051 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -114.44 97.46 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.69 120.16 17.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 111.91 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.13 35.07 24.94 Favored Glycine 0 CA--C 1.557 2.678 0 N-CA-C 118.26 2.064 . . . . 0.0 118.26 -165.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -81.1 143.46 32.41 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.767 0.827 . . . . 0.0 112.437 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -75.07 -3.52 33.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -72.1 104.11 3.5 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 120.522 1.51 . . . . 0.0 111.948 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.31 78.47 9.79 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 122.711 1.243 . . . . 0.0 111.844 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -143.55 130.68 20.71 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.2 -57.85 3.65 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.8 151.06 6.53 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 115.521 0.968 . . . . 0.0 115.521 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -100.0 99.66 9.73 Favored Pre-proline 0 CA--C 1.573 1.85 0 CA-C-O 118.013 -0.994 . . . . 0.0 108.623 166.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.12 -35.7 11.15 Favored 'Trans proline' 0 CA--C 1.564 2.01 0 C-N-CA 122.73 2.287 . . . . 0.0 117.807 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -75.97 132.82 40.44 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 119.217 0.917 . . . . 0.0 112.738 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -52.6 -42.17 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -50.55 -52.33 39.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.33 -44.88 84.61 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.618 1.711 . . . . 0.0 115.618 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -62.83 -53.88 47.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.42 91.33 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -60.64 -48.76 80.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.281 1.4 . . . . 0.0 114.031 167.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.514 HD21 HMB1 ' A' ' 101' ' ' HEC . 20.3 tp -59.32 -45.85 90.2 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 171.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.8 mt -65.5 -32.94 60.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.064 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 173.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.66 86.09 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.907 1.817 . . . . 0.0 115.907 160.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -61.32 -46.04 91.93 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.0 mt -56.15 -40.92 74.6 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -59.25 -45.18 91.88 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.69 14.42 18.62 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.934 2.734 . . . . 0.0 119.934 169.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -132.21 78.26 1.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.654 1.727 . . . . 0.0 107.74 172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.189 0.595 . . . . 0.0 109.586 -174.889 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.64 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_